JPS609514B2 - 7-amino-3'-norcephalosporanic acids - Google Patents
7-amino-3'-norcephalosporanic acidsInfo
- Publication number
- JPS609514B2 JPS609514B2 JP51093809A JP9380976A JPS609514B2 JP S609514 B2 JPS609514 B2 JP S609514B2 JP 51093809 A JP51093809 A JP 51093809A JP 9380976 A JP9380976 A JP 9380976A JP S609514 B2 JPS609514 B2 JP S609514B2
- Authority
- JP
- Japan
- Prior art keywords
- reaction
- chph2
- group
- added
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000002253 acid Substances 0.000 title claims description 14
- 150000007513 acids Chemical class 0.000 title 1
- -1 methyltetrazolylthio group Chemical group 0.000 claims description 39
- 150000001875 compounds Chemical class 0.000 claims description 29
- 125000005843 halogen group Chemical group 0.000 claims description 13
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims description 11
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 8
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 7
- 125000005110 aryl thio group Chemical group 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 125000005278 alkyl sulfonyloxy group Chemical group 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 99
- 238000006243 chemical reaction Methods 0.000 description 76
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 54
- 239000000243 solution Substances 0.000 description 41
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 34
- 238000000034 method Methods 0.000 description 33
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 27
- 239000000203 mixture Substances 0.000 description 26
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 25
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 24
- 239000002904 solvent Substances 0.000 description 22
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 18
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 17
- 239000000284 extract Substances 0.000 description 17
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 16
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Substances C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 16
- 239000000741 silica gel Substances 0.000 description 15
- 229910002027 silica gel Inorganic materials 0.000 description 15
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 14
- 239000011541 reaction mixture Substances 0.000 description 14
- 239000012267 brine Substances 0.000 description 13
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 13
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- 238000001816 cooling Methods 0.000 description 12
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 10
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical class [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 10
- RTEXIPZMMDUXMR-UHFFFAOYSA-N benzene;ethyl acetate Chemical compound CCOC(C)=O.C1=CC=CC=C1 RTEXIPZMMDUXMR-UHFFFAOYSA-N 0.000 description 10
- 239000005457 ice water Substances 0.000 description 10
- 101150041968 CDC13 gene Proteins 0.000 description 9
- MDHYEMXUFSJLGV-UHFFFAOYSA-N beta-phenethyl acetate Natural products CC(=O)OCCC1=CC=CC=C1 MDHYEMXUFSJLGV-UHFFFAOYSA-N 0.000 description 9
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 8
- 125000006364 carbonyl oxy methylene group Chemical group [H]C([H])([*:2])OC([*:1])=O 0.000 description 8
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 239000010410 layer Substances 0.000 description 7
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- 150000001780 cephalosporins Chemical class 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 125000006239 protecting group Chemical group 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 229930186147 Cephalosporin Natural products 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 4
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 4
- 229930182555 Penicillin Natural products 0.000 description 4
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 125000002252 acyl group Chemical group 0.000 description 4
- 125000003118 aryl group Chemical group 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- 229940124587 cephalosporin Drugs 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 239000004020 conductor Substances 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 4
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 4
- 229940049954 penicillin Drugs 0.000 description 4
- 238000006722 reduction reaction Methods 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 239000004593 Epoxy Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical class OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 125000006244 carboxylic acid protecting group Chemical group 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 125000005982 diphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 238000005658 halogenation reaction Methods 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- 238000005694 sulfonylation reaction Methods 0.000 description 3
- DOZRDZLFLOODMB-UHFFFAOYSA-N 3,5-di-tert-Butyl-4-hydroxybenzaldehyde Chemical compound CC(C)(C)C1=CC(C=O)=CC(C(C)(C)C)=C1O DOZRDZLFLOODMB-UHFFFAOYSA-N 0.000 description 2
- RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 description 2
- 101100313763 Arabidopsis thaliana TIM22-2 gene Proteins 0.000 description 2
- 101100537937 Caenorhabditis elegans arc-1 gene Proteins 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical class OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 2
- KPUNOVLMCQQCSK-UHFFFAOYSA-N diazomethane;ethoxyethane Chemical compound C=[N+]=[N-].CCOCC KPUNOVLMCQQCSK-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical group 0.000 description 2
- ZUKSLMGYYPZZJD-UHFFFAOYSA-N ethenimine Chemical class C=C=N ZUKSLMGYYPZZJD-UHFFFAOYSA-N 0.000 description 2
- 238000006266 etherification reaction Methods 0.000 description 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 2
- 230000002140 halogenating effect Effects 0.000 description 2
- 230000026030 halogenation Effects 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- JILPJDVXYVTZDQ-UHFFFAOYSA-N lithium methoxide Chemical compound [Li+].[O-]C JILPJDVXYVTZDQ-UHFFFAOYSA-N 0.000 description 2
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- QXNSHVVNEOAAOF-RXMQYKEDSA-N (6R)-4-oxa-5-thia-1-azabicyclo[4.2.0]oct-2-en-8-one Chemical compound S1OC=CN2[C@H]1CC2=O QXNSHVVNEOAAOF-RXMQYKEDSA-N 0.000 description 1
- IKWLIQXIPRUIDU-ZCFIWIBFSA-N (6r)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound OC(=O)C1=CCS[C@@H]2CC(=O)N12 IKWLIQXIPRUIDU-ZCFIWIBFSA-N 0.000 description 1
- ZQXCQTAELHSNAT-UHFFFAOYSA-N 1-chloro-3-nitro-5-(trifluoromethyl)benzene Chemical compound [O-][N+](=O)C1=CC(Cl)=CC(C(F)(F)F)=C1 ZQXCQTAELHSNAT-UHFFFAOYSA-N 0.000 description 1
- FGOJCPKOOGIRPA-UHFFFAOYSA-N 1-o-tert-butyl 4-o-ethyl 5-oxoazepane-1,4-dicarboxylate Chemical compound CCOC(=O)C1CCN(C(=O)OC(C)(C)C)CCC1=O FGOJCPKOOGIRPA-UHFFFAOYSA-N 0.000 description 1
- HDECRAPHCDXMIJ-UHFFFAOYSA-N 2-methylbenzenesulfonyl chloride Chemical compound CC1=CC=CC=C1S(Cl)(=O)=O HDECRAPHCDXMIJ-UHFFFAOYSA-N 0.000 description 1
- VMZCDNSFRSVYKQ-UHFFFAOYSA-N 2-phenylacetyl chloride Chemical compound ClC(=O)CC1=CC=CC=C1 VMZCDNSFRSVYKQ-UHFFFAOYSA-N 0.000 description 1
- GNFTZDOKVXKIBK-UHFFFAOYSA-N 3-(2-methoxyethoxy)benzohydrazide Chemical compound COCCOC1=CC=CC(C(=O)NN)=C1 GNFTZDOKVXKIBK-UHFFFAOYSA-N 0.000 description 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 240000008564 Boehmeria nivea Species 0.000 description 1
- WSYYVPDFSKSYGK-UHFFFAOYSA-N C(C)(C)(C)[ClH]O.C(C)(C)(C)OCl Chemical compound C(C)(C)(C)[ClH]O.C(C)(C)(C)OCl WSYYVPDFSKSYGK-UHFFFAOYSA-N 0.000 description 1
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 description 1
- 101150070189 CIN3 gene Proteins 0.000 description 1
- 102100022210 COX assembly mitochondrial protein 2 homolog Human genes 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241000931705 Cicada Species 0.000 description 1
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 101000933374 Gallus gallus Brain-specific homeobox/POU domain protein 3 Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 101000900446 Homo sapiens COX assembly mitochondrial protein 2 homolog Proteins 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- 239000003810 Jones reagent Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- SLLIVEFURLIQGI-UHFFFAOYSA-N [Cl].ClC(Cl)(Cl)Cl Chemical compound [Cl].ClC(Cl)(Cl)Cl SLLIVEFURLIQGI-UHFFFAOYSA-N 0.000 description 1
- PJWSWBRTZKODSD-UHFFFAOYSA-N acetic acid;benzene;ethyl acetate Chemical compound CC(O)=O.CCOC(C)=O.C1=CC=CC=C1 PJWSWBRTZKODSD-UHFFFAOYSA-N 0.000 description 1
- DBJUEJCZPKMDPA-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O DBJUEJCZPKMDPA-UHFFFAOYSA-N 0.000 description 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 150000001504 aryl thiols Chemical class 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 description 1
- BRQWNZNDFGGBIS-UHFFFAOYSA-N benzhydryl 2-(triphenyl-$l^{5}-phosphanylidene)acetate Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(C=1C=CC=CC=1)=CC(=O)OC(C=1C=CC=CC=1)C1=CC=CC=C1 BRQWNZNDFGGBIS-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- KFCUPNHUPHDVJC-UHFFFAOYSA-N bromine azide Chemical compound BrN=[N+]=[N-] KFCUPNHUPHDVJC-UHFFFAOYSA-N 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L calcium carbonate Substances [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- RBHJBMIOOPYDBQ-UHFFFAOYSA-N carbon dioxide;propan-2-one Chemical compound O=C=O.CC(C)=O RBHJBMIOOPYDBQ-UHFFFAOYSA-N 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- WLXALCKAKGDNAT-UHFFFAOYSA-N diazoethane Chemical compound CC=[N+]=[N-] WLXALCKAKGDNAT-UHFFFAOYSA-N 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 150000002085 enols Chemical class 0.000 description 1
- 238000006735 epoxidation reaction Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- FRYHCSODNHYDPU-UHFFFAOYSA-N ethanesulfonyl chloride Chemical compound CCS(Cl)(=O)=O FRYHCSODNHYDPU-UHFFFAOYSA-N 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229960004275 glycolic acid Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000012433 hydrogen halide Substances 0.000 description 1
- 229910000039 hydrogen halide Inorganic materials 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- FUKUFMFMCZIRNT-UHFFFAOYSA-N hydron;methanol;chloride Chemical compound Cl.OC FUKUFMFMCZIRNT-UHFFFAOYSA-N 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- ACKFDYCQCBEDNU-UHFFFAOYSA-J lead(2+);tetraacetate Chemical compound [Pb+2].CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O ACKFDYCQCBEDNU-UHFFFAOYSA-J 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000012254 powdered material Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- TVDSBUOJIPERQY-UHFFFAOYSA-N prop-2-yn-1-ol Chemical compound OCC#C TVDSBUOJIPERQY-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- XHFLOLLMZOTPSM-UHFFFAOYSA-M sodium;hydrogen carbonate;hydrate Chemical compound [OH-].[Na+].OC(O)=O XHFLOLLMZOTPSM-UHFFFAOYSA-M 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/568—Four-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Description
【発明の詳細な説明】
本発明は強力な抗菌作用を有するセフアロスポリン新類
似体への重要な合成中間体、特に78−アミノー1ーオ
キサデチアセフアロスポリン類に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to important synthetic intermediates to new analogues of cephalosporins with potent antibacterial activity, particularly 78-amino-1-oxadethiacephalosporins.
本発明化合物を一般式で示すと、次のように表わすこと
ができる。The compound of the present invention can be represented by the following general formula.
(式中、
RIは水素原子、ハロゲン原子、低級アルコキシ基、低
級アルキルスルホニルオキシ基、アリールチオ基または
メチルテトラゾリルチオ基;R2はCOO日または(ニ
トロまたはフエニル)ペンジルオキシカルボニル基:R
3は水素原子またはメトキシ基;
をそれぞれ表わす)
一般式(1)で示される本発明化合物は、以下の反応工
程図1〜8に示す方法で製造することができる。(In the formula, RI is a hydrogen atom, a halogen atom, a lower alkoxy group, a lower alkylsulfonyloxy group, an arylthio group or a methyltetrazolylthio group; R2 is a COO group or a (nitro or phenyl)penzyloxycarbonyl group: R
3 represents a hydrogen atom or a methoxy group; The compound of the present invention represented by the general formula (1) can be produced by the methods shown in the following reaction process diagrams 1 to 8.
一般式(1)において、RIがハロゲン原子またはスル
ホニルオキシ基である化合物(la)は反応工程図−1
に示した方法で製造することができる。In the general formula (1), the compound (la) in which RI is a halogen atom or a sulfonyloxy group is represented by reaction process diagram-1
It can be manufactured by the method shown in .
反応工程図−1
(但し、式中Rはアミノ保護基、R′はカルボン酸保護
基、Xはハロゲン原子またはスルホニルオキシ基をそれ
ぞれ表わす:R2は前述同様の意味を有する)上記工程
における原料物質(n)は公知の物質であり、例えば侍
開昭51−41385号明細書に記載の方法で製造する
ことができる。Reaction process diagram-1 (However, in the formula, R is an amino protecting group, R' is a carboxylic acid protecting group, and X is a halogen atom or a sulfonyloxy group, respectively: R2 has the same meaning as above) Raw material in the above step (n) is a known substance, and can be produced, for example, by the method described in Samurai Publication No. 51-41385.
また、本発明者らの方法により、次の反応工程図−2に
従って製造してもよい。反応工程図−2
(但し、式中X′およびX″はそれぞれハロゲン原子、
R″はェステル残基をそれぞれ表わす:RおよびR′は
前述同様の意味を有する)上記反応工程図−2における
反応は、各上程ごとに示した反応工程を満足する公知の
反応条件に従って行えばよい。Alternatively, it may be produced according to the following reaction process diagram-2 according to the method of the present inventors. Reaction process diagram-2 (However, in the formula, X' and X'' are each a halogen atom,
R'' each represents an ester residue; R and R' have the same meanings as described above) The reaction in the above reaction process diagram-2 can be carried out according to known reaction conditions that satisfy the reaction steps shown in each step. good.
反応工程図一1に示した工程により得られる化合物(l
a)は一般式(1)のRIがハロゲン原子またはスルホ
ニルオキシ基、R2が同意義、R3が水素原子である化
合物に相当する。The compound (l) obtained by the process shown in Reaction Process Diagram 1
a) corresponds to a compound of general formula (1) in which RI is a halogen atom or a sulfonyloxy group, R2 has the same meaning, and R3 is a hydrogen atom.
反応工程図一1に示した各工程の反応条件を詳しく説明
すると次のとおりである。工程a(0→m)
3位の水酸基をハロゲン原子に置き換えるか、スルホニ
ル化剤でスルホニル化して、所望の3−ハロゲン体ある
いは3−スルホニルオキシ体とする。Reaction Steps The reaction conditions for each step shown in Figure 1 are explained in detail as follows. Step a (0→m) The hydroxyl group at the 3-position is replaced with a halogen atom or sulfonylated with a sulfonylating agent to obtain the desired 3-halogen or 3-sulfonyloxy compound.
3位水酸基のハロゲン化反応は、通常水酸基のハロゲン
化に利用される反応方法(例えば三ハロゲン化リンPX
3、塩化チオニルなどによる方法)によっても達成可能
であるが、本発明においては既知のハロゲン化方法の内
、特にハロゲン化オキサリル(例、塩化オキサリル)、
オキシハロゲン化リン(例、オキシ塩化リン)、ハロゲ
ン(例、塩素)−トリフェニルホスフィンなどによる反
応法が、好ましい方法として適用される。The halogenation reaction of the 3-position hydroxyl group is carried out using a reaction method normally used for halogenation of a hydroxyl group (for example, phosphorus trihalide PX).
However, in the present invention, among known halogenation methods, oxalyl halides (e.g., oxalyl chloride),
A reaction method using phosphorus oxyhalide (eg, phosphorus oxychloride), halogen (eg, chlorine)-triphenylphosphine, etc. is applied as a preferred method.
3位水酸基のスルホニル化反応は、通常水酸基のスルホ
ニル化反応と同様に行うことができる。The sulfonylation reaction of the 3-position hydroxyl group can be carried out in the same manner as the sulfonylation reaction of the hydroxyl group.
スルホニル化剤の具体例としては、ハロゲン化アルキル
スルホニル(塩化メチルスルホニル、塩化エチルスルホ
ニルなど)、ハロゲン化アリールスルホニル(塩化ベン
ゼンスルホニル、塩化トルヱンスルホニルなど)が挙げ
られる。反応は通常のスルホニル化反応の条件に従って
、例えば、ピリジン、トリェチアミンなどの第三級アミ
ンの存在下、上記ハロゲン化剤を反応せしめることによ
り行う。工程b(m→la)
この工程では、7位アミノ保護基と、必要に応じて4位
カルボン酸保護基とを同時に、または段階的に、保護基
の性質に応じて水解的にもしくは還元的に除去する。Specific examples of the sulfonylating agent include alkylsulfonyl halides (methylsulfonyl chloride, ethylsulfonyl chloride, etc.) and arylsulfonyl halides (benzenesulfonyl chloride, toluenesulfonyl chloride, etc.). The reaction is carried out under the usual conditions of a sulfonylation reaction, for example, by reacting the above-mentioned halogenating agent in the presence of a tertiary amine such as pyridine or triethiamine. Step b (m→la) In this step, the 7-position amino protecting group and, if necessary, the 4-position carboxylic acid protecting group are simultaneously or stepwise hydrolytically or reductively added depending on the nature of the protecting group. to be removed.
本発明に使用される7位アミノ保護基および4位カルボ
ン酸保護基は、ペニシリンあるいはセフアロスポリンの
合成化学において通常繁用されるものであり、公知の方
法で容易に脱離除去することができる。一般式(1)に
おいて、RIがハロゲン原子、スルホニルオキシ基以外
のものは、以下の反応工程図のように製造することがで
きる。The 7-position amino protecting group and the 4-position carboxylic acid protecting group used in the present invention are commonly used in the synthetic chemistry of penicillin or cephalosporin, and can be easily removed by known methods. In general formula (1), when RI is other than a halogen atom or a sulfonyloxy group, it can be produced as shown in the reaction process diagram below.
反応工程図−3
(但し、式中R、R1、R2およびXは前述同様の意味
を有する。Reaction Process Diagram-3 (However, in the formula, R, R1, R2 and X have the same meanings as above.
)反応工程図−3は、一般式(1)におけるRIが水素
原子である化合物を製造するための工程を示す。) Reaction process diagram-3 shows a process for producing a compound in which RI in general formula (1) is a hydrogen atom.
工程c(m→W)
一般式(m)で示される化合物の3位ハロゲン原子もし
くはスルホニルオキシ基を還元的に脱離して、3位非置
換のオキサデチアセフヱム骨格を調製する。Step c (m→W) The halogen atom or sulfonyloxy group at the 3-position of the compound represented by the general formula (m) is reductively eliminated to prepare an unsubstituted oxadethiacephim skeleton at the 3-position.
この工程での還元反応は、他の置換基および官能基を損
わずに、特異的に3位ハロゲン原子もしくはスルホニル
オキシ基を還元脱離する方法として、金属と酸の組合せ
、特に亜鉛−酢酸の組合せによる方法が効果的である。
反応は公知の方法に従って行えばよい。工程d(W→l
b)
この工程は前述の工程bと全く同じ目的の水解もし〈は
還元工程であり、ペニシリンあるいはセフアロスポリン
の合成化学で繁用される方法に従って行えばよい。The reduction reaction in this step is performed using a combination of metal and acid, especially zinc-acetic acid, as a method for specifically reducing and eliminating the 3-position halogen atom or sulfonyloxy group without damaging other substituents and functional groups. A combination of these methods is effective.
The reaction may be carried out according to known methods. Process d (W→l
b) This step is a hydrolysis/reduction step that has exactly the same purpose as the above-mentioned step b, and can be carried out according to methods frequently used in the synthetic chemistry of penicillin or cephalosporin.
なおこの工程の目的化合物(lb)は、次の反応工程図
に従って製造してもよい。Note that the target compound (lb) in this step may be produced according to the following reaction process diagram.
(但し、式中RおよびR′は前述同様の意味を有する。(However, in the formula, R and R' have the same meanings as described above.
)* 上記反応工程図−4における反応は、各工程ごと
に示した反応工程を満足する公知の反応条件に従って行
えばよい。)* The reaction in the above reaction process chart-4 may be carried out according to known reaction conditions that satisfy the reaction steps shown for each step.
一般式(1)において、RIがアリールチオ基または単
環性へテロ環チオ基である化合物は、次の反応工程図に
従って製造することができる。A compound in which RI is an arylthio group or a monocyclic heterocyclic thio group in general formula (1) can be produced according to the following reaction scheme.
反応工程図一5(但し、式中R、R1、R2および×は
前述同様の意味を有する:Yはアリールチオ基または単
環性へテロ環チオ基を表わす。Reaction Process Diagram 15 (However, in the formula, R, R1, R2 and x have the same meanings as described above; Y represents an arylthio group or a monocyclic heterocyclic thio group.
)工程e(町→V)
化合物(皿)の3位ハロゲン原子もしくはスルホニルオ
キシ基を、所望のアリールチオ基もしくは単環性へテロ
環チオ基と置換する。) Step e (Machi→V) The 3-position halogen atom or sulfonyloxy group of the compound (plate) is substituted with a desired arylthio group or monocyclic heterocyclic thio group.
本反応は、原料化合物(m)と対応するアリールチオー
ルもしくは単環性へテロ環チオールとを弱塩基の存在下
に反応させるか、あるいは対応するチオールの塩と反応
させればよい。弱塩基としては、ピリジン、トリェチル
アミンなどの有機塩基が特に好ましい。反応は通常、室
温で容易に進行する。工程f(V→lc)この工程は前
述の工程bおよびdと全く同じ目的の水解もしくは還元
工程であり、これらの工程と同様の条件で反応を行うこ
とができる。In this reaction, the starting compound (m) may be reacted with the corresponding aryl thiol or monocyclic heterocyclic thiol in the presence of a weak base, or with a salt of the corresponding thiol. As the weak base, organic bases such as pyridine and triethylamine are particularly preferred. The reaction usually proceeds easily at room temperature. Step f (V→lc) This step is a hydrolysis or reduction step having exactly the same purpose as the above-mentioned steps b and d, and the reaction can be carried out under the same conditions as these steps.
また、この工程の目的化合物(lc)は、次の反応工程
図に従って製造することができる。Moreover, the target compound (lc) of this step can be produced according to the following reaction process diagram.
反応工程図−6(但し、式中R、RIおよびYは前述同
様の意味を有する。Reaction Process Diagram-6 (However, in the formula, R, RI and Y have the same meanings as above.
)★ 上言己反応工程図−6における反応は、各工程ご
とに示した反応工程を満足する公知の反応条件に従って
行えばよい。)★ The reaction in the above self-reaction process diagram-6 may be carried out according to known reaction conditions that satisfy the reaction steps shown for each step.
一般式(1)において、RIが低級アルコキシ基である
化合物は、次の反応工程図に従って製造することができ
る。A compound in which RI is a lower alkoxy group in general formula (1) can be produced according to the following reaction scheme.
反応工程図−7
(但し、式中R、R′およびR2は前述同様の意味を有
する:R…は低級アルキル基を表わす。Reaction Process Diagram-7 (However, in the formula, R, R' and R2 have the same meanings as described above: R... represents a lower alkyl group.
)工程g(0→W)この工程の反応は、ケトンのヱノー
ルェーテル化反応の条件に従って行うか、あるいはジア
ゾアルカンなど通常カルボン酸のェステル化に利用する
試薬を用いて行う。) Step g (0→W) The reaction in this step is carried out according to the conditions for the enol etherification reaction of ketones, or is carried out using a reagent such as diazoalkane that is usually used for esterification of carboxylic acids.
ケトンのェノールェーテル化反応とは、例えば、トリア
ルキルオルト蟻酸ェステル(例:トリェチルオルト蟻酸
ェステル)な*どを使用する反応、アルコールとpート
ルェンスルホン酸による反応などである。また、ジアゾ
アルカン(ジアゾメタン、ジアゾエタンなど)によるア
ルキル化反応も本発明においては髪湯される。これらの
反応はそれぞれ公知の反応法に従って行えばよい。工程
h(W→ld)
この工程の反応は、前述の工程b、d、fと全く同じ水
解もし〈は還元反応を目的とする工程であり、これらの
工程と同じ条件で反応を行うことができる。The phenol etherification reaction of a ketone includes, for example, a reaction using a trialkylorthoformate (eg, triethyl orthoformate), a reaction between an alcohol and p-toluenesulfonic acid, and the like. Furthermore, alkylation reactions using diazoalkanes (diazomethane, diazoethane, etc.) are also carried out in the present invention. These reactions may be carried out according to known reaction methods. Step h (W → ld) The reaction in this step is exactly the same as the above-mentioned steps b, d, and f, and the objective is a reduction reaction, and the reaction can be carried out under the same conditions as these steps. can.
一般式(1)において、R3がメトキシ基である化合物
は、次の反応工程図に従って製造することができる。A compound in which R3 is a methoxy group in general formula (1) can be produced according to the following reaction scheme.
反応工程図−8
(但し、式中RIおよびR2は前述同機の意味を有する
)工程
原料化合物(lf)は上述反応工程図1〜7により得ら
れる各自的化合物に相当する。Reaction Process Diagram-8 (However, in the formula, RI and R2 have the same meanings as those described above.) The process raw material compound (lf) corresponds to each compound obtained according to the reaction process diagrams 1 to 7 described above.
反応工程図−8に示した7位メトキシ基の導入には、ペ
ニシリンおよびセフアロスポリンの化学において一般に
利用される7−メトキシ基導入法がそのまま適用できる
。それらの方法を詳説すれば次のとおりである。方法1
原料化合物(lf)の7−アミ/基をアシル化して、対
応する7ーアシルアミノ体とし、これにメトキシリチウ
ム(LiOCH3)および次亜塩素酸・t−ブチル(t
−BuOCI)を下宿性溶媒中低温で反応せしめる(ベ
ルギー特許第817836号)。For the introduction of the methoxy group at the 7-position shown in Reaction Process Diagram-8, the 7-methoxy group introduction method commonly used in the chemistry of penicillin and cephalosporin can be applied as is. The details of these methods are as follows. Method 1 The 7-ami/group of the starting compound (lf) is acylated to give the corresponding 7-acylamino compound, which is then treated with methoxylithium (LiOCH3) and t-butyl hypochlorite (t-butyl hypochlorite).
-BuOCI) at low temperature in a boarding solvent (Belgium Patent No. 817836).
次いで、7位アシル保護基を除去する。方法2
原料化合物(lf)の7ーアミノ基に亜硝酸ナトリウム
を反応せしめて7−ジアゾ体{a)とし、これにハロァ
ジド(ナトリウムアジドと対応するハロゲンから調製す
る)(例:BrN3・CIN3、IN3)を反応せしめ
て対応するハロアジド体‘bーとし、次いでこれにメタ
ノールを反応せしめて、更に還元的にアジドを分解して
やれば、所望の7−アミノ−7ーメトキシ体(le)が
得られる。The 7-position acyl protecting group is then removed. Method 2 The 7-amino group of the raw material compound (lf) is reacted with sodium nitrite to form a 7-diazo compound {a), which is then treated with haloazide (prepared from sodium azide and the corresponding halogen) (e.g. BrN3, CIN3, IN3). ) is reacted to form the corresponding haloazide 'b-, which is then reacted with methanol to further reductively decompose the azide to obtain the desired 7-amino-7-methoxy form (le).
本工程を反応式により説明すると、次のように表わすこ
とができる。(特閥昭47一931)(但し、式中RI
およびR2は前述同様の意味を有する;×′′′はハロ
ゲン原子を表わす。This process can be expressed as follows using a reaction formula. (Tokubatsu Showa 47-1931) (However, in the formula RI
and R2 have the same meanings as above; x''' represents a halogen atom.
)方法3
原料化合物(lf)にp−ヒドロキシベンズアルデヒド
(特にp−ヒドロキシの隣接位に嵩高い置換基を有する
、例えば3・5ージーtーブチル−4−ヒドロキシベン
ズアルデヒドが好ましい)を反応せしめてペンジリデン
議導体【c’とし、これを適当な酸化剤(例:過酸化ニ
ッケル、四酢酸鉛)で酸化してキノイド型誘導体【dー
とし、これにメタノールを反応させて、7Qーメトキシ
体‘eーとした後、ベンジリデン基を水解(通常ジラー
ル試薬により処理する)してやると、所望の78−ァミ
ノ−7Q−メトキシ体(le)が得られる。) Method 3 The raw material compound (lf) is reacted with p-hydroxybenzaldehyde (particularly preferred is 3,5-di-tert-butyl-4-hydroxybenzaldehyde, which has a bulky substituent at the position adjacent to p-hydroxy) to form penzylidene molecule. The conductor [c' is oxidized with an appropriate oxidizing agent (e.g. nickel peroxide, lead tetraacetate) to form a quinoid derivative [d-], which is reacted with methanol to form a 7Q-methoxy derivative 'e-. After that, the benzylidene group is hydrolyzed (usually treated with a Girard reagent) to obtain the desired 78-amino-7Q-methoxy compound (le).
本工程を反応式により説明すると、次のように表わすこ
とができる。(袴関昭50−50394)(但し、式中
RIおよびR2は前述同機の意味を有する。)方法4
その他の方法としては下記反応式のごとき方法も利用で
きる。This process can be expressed as follows using a reaction formula. (Hakama Seki Sho 50-50394) (However, in the formula, RI and R2 have the same meanings as those mentioned above.) Method 4 As another method, a method such as the following reaction formula can also be used.
即ち、原料化合物(lf)の7位アミノ基を、Q位に少
くとも1ケの水素原子を有するァシル基で保護し、この
7ーアシルアミノ誘導体【flをハロゲン化剤と処理し
てィミノハラィド議導体(g)とし、これを塩基と処理
してハロゲン化水素を脱離せしめ、得られるケテンィミ
ン誘導体(h)をハロゲン化してジハロゲノイミン譲導
体(i)とし、これにアルカリ金属メトキシドを反応せ
しめ、次いで適宜水解して、アシル基を除去する。(特
開昭50一126692)(但し、式中RIおよびR2
は前述同様の意味を有する;Q′およびQ″は水素原子
または適当な置換基を、XおよびX′はハロゲン原子を
それぞれ表わす。That is, the amino group at the 7-position of the starting compound (lf) is protected with an acyl group having at least one hydrogen atom at the Q-position, and this 7-acylamino derivative [fl] is treated with a halogenating agent to form an iminohalide derivative ( g), which is treated with a base to eliminate hydrogen halide, and the obtained keteneimine derivative (h) is halogenated to give a dihalogenoidine derivative (i), which is reacted with an alkali metal methoxide, and then subjected to appropriate hydrolysis. to remove the acyl group. (JP 50-126692) (However, in the formula RI and R2
have the same meanings as above; Q' and Q'' each represent a hydrogen atom or a suitable substituent, and X and X' each represent a halogen atom.
)一般式(1)で表わされる本発明化合物は、新しい型
の1−オキサデチアセフアロスポリン類を製造する上で
の重要な合成中間体となるものであり、本発明化合物(
1)の7位遊離アミノ基に、ペニシリンあるいはセフア
ロスポリン化学の領域で常用される種々のァシル基を導
入することにより、強力な抗菌作用を示す化合物を得る
ことができる。) The compound of the present invention represented by the general formula (1) serves as an important synthetic intermediate in the production of new types of 1-oxadethiacephalosporins, and the compound of the present invention (
By introducing various acyl groups commonly used in the field of penicillin or cephalosporin chemistry into the free amino group at position 7 of 1), compounds exhibiting strong antibacterial activity can be obtained.
以下に本発明方法実施の態様を示す。The embodiments of the method of the present invention are shown below.
実施例 1
78−アミノー3−クロル−1−オキサー1−デチア−
3−セフェム−4−カルボン酸(la:RI=CI;R
2=COOH;R3=H)(la:R2:C〇〇H:X
=CI)‘1’ 78−ペンジルオキシカルボニルアミ
ノ−3−ヒドロキシ−1−オキサ−1ーデチア−3ーセ
フヱム−4−カルボン酸・ジフェニルメチルヱステル(
0:R:PhCH20C○;R′=CHPh2)1.5
夕(3のmol)をジメチルホルムアミド30の【にと
かし、氷水冷却下、これにピリジン0.03M(0.3
6mmole)を加え、次いで塩化オキサリル0.31
の‘(3.6のmole)を滴下する。Example 1 78-amino-3-chloro-1-oxer-1-dethia-
3-cephem-4-carboxylic acid (la:RI=CI;R
2=COOH; R3=H) (la:R2:C〇〇H:X
=CI)'1' 78-penzyloxycarbonylamino-3-hydroxy-1-oxa-1-dethia-3-cephem-4-carboxylic acid diphenylmethylester (
0:R:PhCH20C○;R'=CHPh2)1.5
Dimethylformamide (3 mol) was dissolved in 30 ml of dimethylformamide, and 0.03 M (0.3 mol) of pyridine was added to this under cooling with ice water.
6 mmole) and then 0.31 oxalyl chloride
(3.6 moles).
室温で3時間蝿梓後、反応液を5%リン酸氷水中に注ぎ
、酢酸エチルで抽出する。抽出液を水洗、乾燥後、溶媒
留去し、得られる残澄を2折音量のシリカゲルカラムに
通して、ベンゼン−酢酸エチル(5:1)で溶出すると
、目的の3ークロル体、76ーベンジルオキシカルボニ
ルアミノ−3ークロル−1−オキサー1ーデチア−3−
セフェム−4ーカルボン酸・ジフェニルメチルエステル
(m:R=PhCQOCO;R′=CHPh2:X=C
I)489の9(収率31.4%)が得られる。mp1
30〜13100。IR:ひ生鷲〆3肌−・:3450
、 1805、1725、1620。NMR: 6(C
DCl3)肌:4,32(s、2H)、4,98(d、
Jニ4.0HZ、IH)、5.10(s、2H)、5.
20〜5.80(m、汎)「6.97(s、IH)、7
.0(m、芳香環プロトン)。本品は次の方法によって
も製造できる。After stirring at room temperature for 3 hours, the reaction solution was poured into 5% phosphoric acid in ice water and extracted with ethyl acetate. After washing the extract with water and drying, the solvent was distilled off, and the resulting residue was passed through a 2-fold volume silica gel column and eluted with benzene-ethyl acetate (5:1) to obtain the desired 3-chloro compound and 76-benzyl compound. Oxycarbonylamino-3-chloro-1-oxer-1-dethia-3-
Cephem-4-carboxylic acid diphenylmethyl ester (m:R=PhCQOCO;R'=CHPh2:X=C
I) 9 of 489 (yield 31.4%) is obtained. mp1
30-13100. IR:Hibuwashi〆3hada-・:3450
, 1805, 1725, 1620. NMR: 6(C
DCl3) Skin: 4,32 (s, 2H), 4,98 (d,
Jni 4.0HZ, IH), 5.10 (s, 2H), 5.
20-5.80 (m, general) "6.97 (s, IH), 7
.. 0 (m, aromatic ring proton). This product can also be manufactured by the following method.
トリフエニルホスフイン1.62夕(6.2mmole
)をテトラヒドロフラン20舷にとかし、これに、氷水
冷却鷹梓下、塩素−四塩化炭素溶液6.2mmoleを
加える。Triphenylphosphine 1.62 mmole (6.2 mmole)
) was melted over 20 vessels of tetrahydrofuran, and 6.2 mmole of chlorine-carbon tetrachloride solution was added thereto under ice-water cooling.
次いで、この溶液に、3−ヒドロキシ体(ロ:R=Ph
CH20CO:R=CHPh2)1.55夕(3.1の
mole)とテトラヒドロフラン10の‘よりなる溶液
を加え、更にトリエチルアミン0.86の‘(6.2の
mole)を加える。反応液を室温で1.5時間燈拝し
た後、氷水中に注ぎ、酢酸エチルで抽出する。抽出液を
水洗、乾燥、溶媒留去し、得られる残澄を3ぴ音量のシ
リカゲルカラムに通して、ベンゼン−酢酸エチル(10
:1)で溶出すると、目的の3−クロル体(m:R=P
hCH20CO;R′=CHPh2;×=CI)0.9
5夕(収率59.0%)が得られる。‘2’上記3ーク
ロル体(皿:R=PhCH20CO;R′=CHPh2
:×:CI)950の9(1.83mmole)を塩化
メチレン37叫にとかし、それにアニソール1.78の
【(16.5mmole)を加える。この溶液に、塩化
アルミニウム1.45夕(11mmole)とニトロメ
タン18のの)らなる溶液を加え、室温に一夜放贋する
。反応液に氷冷2%塩酸15の‘を加え、水層を塩化メ
チレンおよび酢酸エチルで順次洗浄し、減圧下に溶媒蟹
去する。残澄をダイヤイオンHP20(三菱化成商標;
ハィポーラスポリマー)400夕のカラムに通して、p
H3の水で溶出する。熔出液をpH4.4に濃縮すると
、目的の遊離3ークロル体(1:R′=CI;R2=C
OOH;R3=H)175の9(収率43.8%)が得
られる。・R:路暮奉加‐1:3420・181816
30・1613実施例 278ーアミノー1ーオキサ−
1−デチアー3−セフェム−4ーカルボン酸(1:RI
=R3=H;R2=COOH)(lb:R2=COOH
)【1} 3ーヒドロキシ体(0:R=PhCH20C
O;R=CHPh2)1.斑夕(3.96mmole)
をジメチルホルムアミド20私にとかし、これに塩化メ
チルスルホニル0.62の‘(2当量)を−50ooで
加え、次いでトリェチルアミン0.83の上(1.5当
量)を加えて、同温で13分間鷹拝する。Next, the 3-hydroxy form (R=Ph
A solution of 1.55 mol (3.1 mole) of CH20CO:R=CHPh2) and 10 mol of tetrahydrofuran is added, followed by 0.86 mol of triethylamine (6.2 mole). After the reaction solution was heated at room temperature for 1.5 hours, it was poured into ice water and extracted with ethyl acetate. The extract was washed with water, dried, and the solvent was distilled off, and the resulting residue was passed through a silica gel column with a volume of 3 pips, and benzene-ethyl acetate (10
:1), the target 3-chloride (m:R=P
hCH20CO; R'=CHPh2; x=CI) 0.9
5 days (yield 59.0%) is obtained. '2' The above 3-chloride (dish: R=PhCH20CO; R'=CHPh2
Dissolve 9 (1.83 mmole) of CI) 950 in methylene chloride and add 1.78 mmole of anisole (16.5 mmole) to it. A solution consisting of 1.45 mmoles (11 mmoles) of aluminum chloride and 18 mmoles of nitromethane is added to this solution and allowed to stand at room temperature overnight. 15 parts of ice-cold 2% hydrochloric acid was added to the reaction mixture, and the aqueous layer was washed successively with methylene chloride and ethyl acetate, and the solvent was removed under reduced pressure. The residual liquid is Diaion HP20 (Mitsubishi Chemical trademark;
high porous polymer) through a column of 400 p
Elute with H3 water. When the eluate was concentrated to pH 4.4, the desired free 3-chloride (1:R'=CI; R2=C
OOH; R3=H) 9 of 175 (yield 43.8%) is obtained.・R: Rikkou Houka-1:3420・181816
30.1613 Example 278-amino-1-oxa-
1-Dethia 3-cephem-4-carboxylic acid (1:RI
=R3=H;R2=COOH)(lb:R2=COOH
) [1} 3-hydroxy form (0:R=PhCH20C
O; R=CHPh2)1. Madarayu (3.96mmole)
was dissolved in 20% dimethylformamide, 0.62% (2 equivalents) of methylsulfonyl chloride was added to this at -50%, then 0.83% (1.5 equivalents) of triethylamine was added, and the mixture was heated at the same temperature for 13 minutes. worship the hawk.
反応液を氷水中に注ぎ、析出する結晶を炉取すると、目
的の3−メチルスルホニルオキシ体、78ーベンジルオ
キシカルボニルアミノー3ーメチルスルホニルオキシー
1−オキサー1−デチア−3−セフェム−4−カルボン
酸・ジフェニルメチルェステル(m:RニPhCH20
C0;R′:CHPh2;X=OS02CH3)2.1
5夕(収率94.0%)が得られる。IR:ひ錦袋3伽
‐1:3420、1810・1730・1510、13
65、11650NMR:8(CDCl3)跡:2.9
6(s、汎)、4.46(広、2H)、4,97(d、
J:4.0日2、IH)、5.07(s、が)、5.4
5(dd.、J=4.0HZ、IH)。【2) 上記3
ーメチルスルホニルオキシ体(m:R=PhCH20C
O;R′=CHPh2:X=OS02CH3)1.15
夕(2のmole)を塩化メチレン20の‘および酢酸
40のとの混液にとかし、これに活性亜鉛末3夕を加え
、室温で一夜縄拝する。この間、反応開始2時間および
3時間目に、各3夕の亜鉛末を追加する。反応混合物よ
り亜鉛末を炉去し、酢酸エチルを加えて、有機層を水洗
、乾燥後、減圧下に溶媒留去すると、目的の3−デオキ
シ体、78−ペンジルオキシカルボニルアミノー1ーオ
キサー1ーデチアー3ーセフエムー4ーカルボン酸・ジ
フェニルメチルェステル(W:R=PhCH20CO;
R′=CHPh2)913泌(収率94.2%)が粉末
状物質として得られる。IR:レ鴇舷多3伽‐1:34
50、1800、1730、1650。NMR:6(C
DC13)跡:4.41(m、汎)、4.95(d、J
=4.0HZ、IH)、5.15(s、が)、5.53
(dd.、J=4.0、9.0HZ、IH)、6.51
(m、IH)、6.99(S、IH)。本品は次の方法
によっても製造できる。実施例1において得られる3ー
クロル体
(皿:R=PhCH2○C〇;R′=CHPh2;X=
CI)240の9を、塩化メチレン4の【および酢酸8
の‘の混液にとかし、活性亜鉛末0.72夕を加えて、
室温で鷹拝する。The reaction solution was poured into ice water and the precipitated crystals were collected in a furnace to obtain the desired 3-methylsulfonyloxy compound, 78-benzyloxycarbonylamino-3-methylsulfonyloxy-1-oxer-1-dethia-3-cephem-4-. Carboxylic acid diphenylmethyl ester (m:R-PhCH20
C0;R':CHPh2;X=OS02CH3)2.1
5 ml (yield 94.0%) is obtained. IR:Hinishikibukuro 3-1:3420, 1810, 1730, 1510, 13
65, 11650 NMR: 8 (CDCl3) Trace: 2.9
6 (s, wide), 4.46 (wide, 2H), 4,97 (d,
J: 4.0 days 2, IH), 5.07 (s, ga), 5.4
5 (dd., J=4.0HZ, IH). [2] 3 above
-Methylsulfonyloxy compound (m:R=PhCH20C
O;R'=CHPh2:X=OS02CH3)1.15
Dissolve 2 moles of dichloromethane in a mixture of 20 moles of methylene chloride and 40 moles of acetic acid, add 3 moles of activated zinc powder, and let stand overnight at room temperature. During this time, 3 doses of zinc powder were added at 2 and 3 hours after the start of the reaction. Zinc powder was removed from the reaction mixture in an oven, ethyl acetate was added, the organic layer was washed with water, dried, and the solvent was distilled off under reduced pressure to obtain the desired 3-deoxy compound, 78-penzyloxycarbonylamino-1-oxer-1. -dethia 3-cephemu 4-carboxylic acid diphenylmethyl ester (W:R=PhCH20CO;
R'=CHPh2)913 secretion (yield 94.2%) is obtained as a powdered material. IR:Re Tokuda 3-1:34
50, 1800, 1730, 1650. NMR: 6(C
DC13) Trace: 4.41 (m, wide), 4.95 (d, J
=4.0HZ, IH), 5.15 (s, ga), 5.53
(dd., J=4.0, 9.0HZ, IH), 6.51
(m, IH), 6.99 (S, IH). This product can also be manufactured by the following method. 3-chloride obtained in Example 1 (dish: R=PhCH2○C〇; R'=CHPh2; X=
CI) 240 of 9, methylene chloride 4 of [and acetic acid 8
Dissolve the mixture and add 0.72 g of activated zinc powder,
Serve at room temperature.
反応開始4時間ないし9時間の間に、各0.72夕の亜
鉛末を3回追加し、鷹梓下に一夜放置する。反応混合物
より亜鉛末を炉去し、炉液を水中に注ぎ、酢酸エチルで
抽出する。抽出液を水洗、乾燥後、濃縮し、得られる残
澄をシリカゲルのカラムに通して、ベンゼン−酢酸エチ
ル(5:1)で溶出すると、目的の3ーデオキシ体(N
:R=PhCH2−OCO;R′=CHPh2)215
雌(収率96.0%)が得られる。湖上記3ーデオキシ
体(W:R=
PhCH20C。During the period from 4 to 9 hours after the start of the reaction, 0.72 g of zinc powder was added three times each time, and the mixture was left under a hawk bed overnight. The zinc powder was removed from the reaction mixture in an oven, the solution was poured into water, and extracted with ethyl acetate. The extract was washed with water, dried, and concentrated. The resulting residue was passed through a silica gel column and eluted with benzene-ethyl acetate (5:1) to obtain the desired 3-deoxy form (N
:R=PhCH2-OCO;R'=CHPh2)215
Females (yield 96.0%) are obtained. The above 3-deoxy form (W:R=PhCH20C.
;R′ニCHPh2)913燐(18,8のmole)
を塩化メチレン35の‘‘ことかし、これにアニソール
1.85の‘(9当量)を加え、更に、塩化アルミニウ
ム1.51夕(6当量)とニトロメタン1鰍【より成る
溶液を加え、室温に一夜放置する。反応混合物を氷冷下
に2%塩酸で抽出し、抽出水層を塩化メチレンおよび酢
酸エチルで洗浄する。水層にとげ込んでいる有機溶媒を
減圧下に轡去し、ダイヤイオンHP20(三菱化成商標
;ノ・ィボーラスポリマー)のカラムに通して、稀塩酸
(pH3.0)で溶出、溶出液を減圧濃縮すると、目的
の3ーオキサセフェム体(1:RI=R3=H;R2=
COOH)塩酸塩291の9(70.6%収率)が得ら
れる。〔ぱ〕色4.5十11.r士2.4(c=0.2
10メタ/‐ル)。IR:レ鰭去肌‐1:3500、2
600、1805、1645、1610、1550。N
MR:6(CD30D)5.37(d、J=4.0日2
、IH)、5.51(d、J=4.0HZ、IH)、6
.70(m、IH)柳o実施例 3
78−アミノー3一(1−メチルテトラゾール−5−イ
ル)チオ−1−オキサ−1−デチア−3−セフェム−4
−カルポン酸(1:RI=1−メチルテトラゾールー5
−イルチオ;R2=COOH:R3=H)(le:Y=
1ーメチルテトラゾール−5ーイルチオ;R2=COO
H)【1ー 実施例2で得られる3ーメチルスルホニル
オキシ体(虹:R=PhCH20CO;R′=CHPH
2:×=OS02CH3)1.12夕(1.94mmo
le)をジメチルホルムアミド10叫にとかし、0℃に
冷却して、これに1ーメチルテトラゾール一5ーイルチ
オール373M(3.2mmole)およびトリエチル
アミン0.42の‘(3.0mmole)を加え、室温
で一夜損拝する。;R'CHPh2) 913 phosphorus (18,8 mole)
To this, add 1.85 ml of anisole (9 equivalents) to methylene chloride, add a solution consisting of 1.51 ml of aluminum chloride (6 equivalents) and 1 ml of nitromethane, and leave at room temperature. Leave it overnight. The reaction mixture was extracted with 2% hydrochloric acid under ice cooling, and the extracted aqueous layer was washed with methylene chloride and ethyl acetate. The organic solvent in the aqueous layer was evaporated under reduced pressure, and the eluate was passed through a column of Diaion HP20 (Mitsubishi Kasei trademark; No Bolus Polymer) and eluted with dilute hydrochloric acid (pH 3.0). Concentration under reduced pressure yields the desired 3-oxacephem (1:RI=R3=H; R2=
COOH) hydrochloride 291 of 9 (70.6% yield) is obtained. [Pa] Color 4.511. r 2.4 (c=0.2
10 meta/-le). IR: Re-fin skin-1:3500, 2
600, 1805, 1645, 1610, 1550. N
MR: 6 (CD30D) 5.37 (d, J = 4.0 days 2
, IH), 5.51 (d, J=4.0HZ, IH), 6
.. 70(m,IH)YanagiO Example 3 78-Amino-3-(1-methyltetrazol-5-yl)thio-1-oxa-1-decithia-3-cephem-4
-carboxylic acid (1:RI=1-methyltetrazole-5
-ylthio; R2=COOH:R3=H) (le:Y=
1-methyltetrazol-5-ylthio; R2=COO
H) [1-3-methylsulfonyloxy compound obtained in Example 2 (Rainbow: R=PhCH20CO; R'=CHPH
2:×=OS02CH3) 1.12 evening (1.94 mmo
le) in dimethylformamide, cooled to 0°C, 373 M (3.2 mmole) of 1-methyltetrazol-5-ylthiol and 0.42 M (3.0 mmole) of triethylamine were added thereto, and the mixture was stirred overnight at room temperature. to worship.
反応終了後、反応液を氷水中に注ぎ、生成する黄色沈澱
物を炉取し、洗浄、乾燥すると、目的の3−テトラゾリ
ルチオ誘導体(V:R=PhC比OCO;R′=CHP
h2:Y二1−メチルテトラゾール−5ーイルチオ)1
.007夕(収率86.7%)が黄色粉末として得られ
る。IR:ひ碑※3肌‐1:3450、1805173
0。NMR:6(CDCl3)肌:3.93(s、細)
、4.28(ABq、J=18HZ、2H)、5.00
(d、J=4.0日2、IH)、5,17(s、汎)、
5.30〜5.90(m、2H)、6,98(S、IH
)。(2} 上記3ーテトラゾリルチオ誘導体(V:P
hC比OCO;R=CHPh2:Y=1ーメチルテトラ
ゾール一5ーイルチオ)137の8(0.229肌mo
le)を塩化メチレン4の‘にとかし、これにアニソー
ル0.223の‘(2.06mmole)を加え、次い
で、塩化アルミニウム190の9(1.4mmole)
およびニトロメタン2の‘からなる溶液を加える。After the reaction is completed, the reaction solution is poured into ice water, and the resulting yellow precipitate is collected in an oven, washed, and dried to obtain the desired 3-tetrazolylthio derivative (V:R=PhC ratio OCO; R'=CHP
h2:Y21-methyltetrazol-5-ylthio)1
.. 007 (yield 86.7%) is obtained as a yellow powder. IR: Hi Monu *3 Skin-1:3450, 1805173
0. NMR: 6 (CDCl3) Skin: 3.93 (s, fine)
, 4.28 (ABq, J=18HZ, 2H), 5.00
(d, J = 4.0 days 2, IH), 5,17 (s, pan),
5.30-5.90 (m, 2H), 6,98 (S, IH
). (2} The above 3-tetrazolylthio derivative (V:P
hC ratio OCO; R=CHPh2:Y=1-methyltetrazol-15-ylthio) 137 to 8 (0.229 skin mo
le) in 4 parts of methylene chloride, add 0.223 parts of anisole (2.06 mmole), and then dissolve 190 parts of aluminum chloride (1.4 mmole).
and nitromethane 2' is added.
反応混合物を室温に一夜放置し、次いで、氷冷下に2%
塩酸3の上を加える。水層を塩化メチレンおよび酢酸エ
チルで順次洗浄した後、濃縮する。この濃縮液に炭酸ナ
トリウムを加えてpH2.5に調整すると、目的の76
−アミノー3ーテトラゾ1」ルチオ誘導体(1:RI:
1−メチルテトラゾール−5ーイルチオ;R2=COO
H:R3=H)2.4柵が結晶として得られる。The reaction mixture was left at room temperature overnight and then diluted with 2%
Add 3 portions of hydrochloric acid. The aqueous layer is washed successively with methylene chloride and ethyl acetate, and then concentrated. When sodium carbonate is added to this concentrated solution and the pH is adjusted to 2.5, the desired 76
-Amino-3-tetrazo 1''ruthio derivative (1:RI:
1-methyltetrazol-5-ylthio; R2=COO
H:R3=H)2.4 fences are obtained as crystals.
mp>20000。IR:ひ麓玉,仇‐1:182o、
1630、1620。実施例 4
78−アミノー3−メトキシー1ーオキサ−1−デチア
ー3−セフェムー4ーカルボン酸(1:RI=OCH3
;R2=COOH;R3=H)(ld:R2=COOH
;R川=CH3)‘1’ 3ーヒドロキシ体(ロ:R=
PhCH20CO:R′:CHPh2)1.15夕(2
.30mmole)を塩化メチレン12の{にとかし、
これにジアゾメタンーエーテル溶液を加え、室温で10
分間燈梓する。mp>20000. IR:Himotodama, enemy-1:182o,
1630, 1620. Example 4 78-Amino-3-methoxy 1-oxa-1-dethia 3-cephemu 4-carboxylic acid (1:RI=OCH3
;R2=COOH;R3=H)(ld:R2=COOH
;R river=CH3)'1' 3-hydroxy body (ro:R=
PhCH20CO:R':CHPh2) 1.15 evening (2
.. 30 mmole) in 12 parts of methylene chloride,
A diazomethane-ether solution was added to this, and 10
Light up for a minute.
反応液を減圧下濃縮し、得られる油状残湾をシリカゲル
50夕のカラムに通して、ベンゼン−酢酸エチル(4:
1)で溶出精製すれば、目的の3−メトキシ体、78ー
ベンジルオキシカルボニルアミノ−3ーメトキシー1ー
オキサー1ーデチアー3ーセフヱムー4ーカルボン酸・
ジフヱニルメチルエステル(川:R=PhCH20CO
;R=CHPh2:R川=CH3)0.89夕(収率7
5%)が得られる。IR:レ視袋3cの‐1:3495
、1796、1725、1626、15120NMR:
6 くCDC13)肌:3.70(s、細)、4.23
および4.54(ABq、J=18HZ、2H)、4.
96(d、J=4.0Hz、IH)、5.18(s、が
)、5.42(dd、J=10および4.0日2、IH
)、5.81(d、J=10HZ、IH)、7.02(
s、IH)、〜7.4(m、芳香環プロトン)。■上記
3−メトキシ体(W:R=PhCH20CO;R′=C
HPh2;R′′′=CH3)1.06夕(2.06m
mole)を塩化メチレン20の‘にとかし、これに冷
時、アニソール3地および三フツ化酢酸3泌を加え、1
5分間櫨拝する。The reaction solution was concentrated under reduced pressure, and the resulting oily residue was passed through a silica gel column of 50 ml, and benzene-ethyl acetate (4:
If the elution and purification is performed in step 1), the desired 3-methoxy form, 78-benzyloxycarbonylamino-3-methoxy 1-oxer 1-dethia 3-cephimu 4-carboxylic acid.
Diphenyl methyl ester (River: R=PhCH20CO
; R = CHPh2: R river = CH3) 0.89 m (yield 7
5%) is obtained. IR: 3c-1:3495
, 1796, 1725, 1626, 15120NMR:
6 CDC13) Skin: 3.70 (s, thin), 4.23
and 4.54 (ABq, J=18HZ, 2H), 4.
96 (d, J = 4.0 Hz, IH), 5.18 (s, ga), 5.42 (dd, J = 10 and 4.0 days 2, IH
), 5.81 (d, J=10HZ, IH), 7.02 (
s, IH), ~7.4 (m, aromatic ring proton). ■The above 3-methoxy form (W: R=PhCH20CO; R'=C
HPh2; R'''=CH3) 1.06 evening (2.06m
mole) in 20 parts of methylene chloride, and when cold, add 3 parts of anisole and 3 parts of acetic acid trifluoride, and make 1 part of the solution.
Pray for 5 minutes.
反応液にトルェン20の‘を加えて減圧濃縮し、得られ
る油状残造をベンゼンにとかし、5%炭酸水素ナトリウ
ム水溶液で抽出する。抽出液をベンゼンで洗浄し「 1
0%塩酸を加えて酸性(pH2)とした後.酢酸エチル
で抽出する。この抽出液を水し食塩水で順次洗浄し、溶
媒を減圧下に蟹去すると、遊離の4−カルボン酸、73
−ペンジルオキシカルボニルアミノー3ーメトキシー1
ーオキサ−1−デチア−3−セフヱム−4−力ルボン酸
0.6Mが得られる。IR:リ錦袋3伽‐1:3430
、1793、172ふ 1630、1510。‘3’5
%パラジウム−炭素100の9を酢酸エチル−メタノー
ル(1:1)混液20の‘に懸濁し、あらかじめ水素ガ
スを吸収させる。この混液に上記遊離の4−カルボン酸
200の9(0.934mmole)を加え、激しく縄
拝しながら水素ガスを吸収させる。室温で2時間損拝し
た後、触媒を炉去し、溶媒を減圧留去すると、目的の7
8−アミノ体〈1:RI=。CH3;R2=COOH;
R3=H> 65の9(収率53%)が得られる。IR
:レ機去伽1:〜340い 〜2900、178ふ16
791647。上記の炉去した触媒を、メタノール−塩
酸で数回洗浄し、洗液を減圧蟹去すると、78−アミノ
体(1:RI=OCH3:R2=COOH;R3=H)
の塩酸塩65の9(収率45%)が白色粉末状結晶とし
て得られる。IR:〃礎主弧‐1:〜乳oo、〜300
0、1787、169ム1619。実施例 573−ア
ミノー3ークロルー7Q−メトキシ−1ーオキサー1ー
デチアー3−セフエムー4ーカルボン酸・p−ニトロベ
ンジルェステル(1:RI=CI:R2=COOCH2
・C6日4・N02−p;R3=OCH3)(le:R
=CI;R2=COOCH2・C6凡・N02−p){
1} 78ーアミノー3−クロルー1−オキサー1−デ
チアー3ーセフェムー4−カラルボン酸・pーニトロベ
ンジルエステル(1:RI=CI;R2;COOCH2
・C6日4・N02一p:R3=H)〔実施例1で得ら
れる遊離3−クロル体(1:RI=CI;R2=COO
H;R3=H)をエステル化することにより得られる〕
141雌(0.399mmole)をクロロホルム7の
‘とベンゼン1の‘との濃液にとかし、これに、3・5
ージーtーブチル−4ーヒドロキシベンズアルデヒド1
12の9(1.2当量)を加え、モノキュラーシーブ入
り脱水管付反応容器中で加熱還流する。Add 20% of toluene to the reaction solution and concentrate under reduced pressure. The resulting oily residue is dissolved in benzene and extracted with a 5% aqueous sodium bicarbonate solution. Wash the extract with benzene and
After making it acidic (pH 2) by adding 0% hydrochloric acid. Extract with ethyl acetate. This extract was washed successively with water and brine, and the solvent was removed under reduced pressure to free 4-carboxylic acid, 73
-penzyloxycarbonylamino-3-methoxy 1
0.6 M of -oxa-1-dethia-3-cefim-4-carboxylic acid is obtained. IR: Rinishikibukuro 3-1:3430
, 1793, 172fu 1630, 1510. '3'5
% palladium-carbon 100% is suspended in 20% ethyl acetate-methanol (1:1) mixture to absorb hydrogen gas in advance. 200 parts (0.934 mmole) of the above-mentioned free 4-carboxylic acid is added to this mixed solution, and hydrogen gas is absorbed while stirring vigorously. After standing at room temperature for 2 hours, the catalyst was removed from the furnace and the solvent was distilled off under reduced pressure.
8-amino body <1:RI=. CH3;R2=COOH;
9 with R3=H>65 (yield 53%) is obtained. IR
:Rekikyo 1: ~340~2900, 178fu16
791647. The catalyst removed from the furnace was washed several times with methanol-hydrochloric acid, and the washings were removed under reduced pressure to form a 78-amino compound (1:RI=OCH3:R2=COOH;R3=H).
Hydrochloride 65:9 (yield 45%) is obtained as white powdery crystals. IR:〃Foundation main arc-1: ~milk oo, ~300
0, 1787, 169mm 1619. Example 57 3-amino-3-chloro-7Q-methoxy-1-oxa-1-dethia-3-cephemu-4-carboxylic acid p-nitrobenzyl ester (1:RI=CI:R2=COOCH2
・C6 day 4・N02-p; R3=OCH3) (le:R
=CI;R2=COOCH2・C6B・N02-p) {
1} 78-amino-3-chloro-1-oxer-1-dethia-3-cephemu-4-caralboxylic acid p-nitrobenzyl ester (1: RI=CI; R2; COOCH2
・C6 day 4・N021p:R3=H) [free 3-chlor form obtained in Example 1 (1:RI=CI;R2=COO
Obtained by esterifying H; R3=H)]
Dissolve 141 females (0.399 mmole) in a concentrated solution of 7 parts of chloroform and 1 part of benzene, and add 3.5 parts to this.
-d-t-butyl-4-hydroxybenzaldehyde 1
9 of 12 (1.2 equivalents) is added, and the mixture is heated to reflux in a reaction vessel containing a monocular sieve and equipped with a dehydration tube.
反応開始2.虫時間後に、アルデヒド30の9を追加し
、更に3.虫時間反応を続ける。次いで、反応混合物を
−15qoに冷却して、硫酸マグネシウム65の9およ
び過酸化ニッケル219の9を加え、同温度で30分間
、次いで室温で40分間損拝する。反応物を炉遇し、炉
液にメタノール5の‘を加えて、室温で1.期時間蝉洋
する。溶媒を減圧留去し、残澄をシリカゲル12夕のカ
ラムに通して、ベンゼン−酢酸エチル(19:1)で溶
出分離すると、目的の7ーメトキシ体、7B−(3・5
−ジーt−プチル−4ーヒドロキシベンジリデン)アミ
ノー3ークロルー7oーメトキシー1ーオキサー1−デ
チアー3ーセフェムー4ーカルポン酸・pーニトロベン
ジルエステル(e:RI=CI;R2=COOCH2・
C6日4・N02−p;78一側鎖=3.5ージーt−
ブチルー4ーヒドロキシベンジリデンアミノ)125の
9(収率52.2%)が飴状物質として得られる。IR
:〃錦舷3弧「:178o、1735、1680、15
20、1345。NMR: 6(CDC13)胸:1.
48(s、1班)、3.61(s、細)、4.49(s
、が)、5.23(s、IH)、5.44(芳香環プロ
トン)、8.53(s、IH)。■ 上記7ーメトキシ
体(e:RI=CI;R2=COOCH2・C6日4・
N02一p;78一側鎖=3・5ージーt−ブチルー4
ーヒドロキシベンジリデンアミノ)125雌をメタノー
ル2.5の‘およびテトラヒドロフラン0.5の‘の混
液にとかし、これにジラール試薬(0jrard T)
81の9を加え、室温で1時間縄拝する。反応物を水中
に注ぎ、塩化メチレンで抽出し、塩化メチレン抽出液を
水洗、乾燥、減圧留去する。得られる残澄をシリカゲル
3.5夕のカラムに通し、ベンゼン−酢酸エチル(4:
1)溶出分画すると、目的の7ーアミノ体(1:RI=
CI;R2=COOCH2・C6伍・N02一p:R3
=OCは)35M(収率43‐8%)が得られる。IR
:レ鴇燕と3肌「:1790、1740、1520、1
350。NMR: 6(CDC13)柳:1.83(戊
、が)、3.53(s、細)、4.54(s、班)、5
.01(s、IH)、5.47(split、が)、7
.67(d、J=9日2、IH)、8.28(d、J:
9日2、IH)、8.28(d、J=9HZ、IH)。
同様に上記いずれかの方法により次の化合物が得られる
。Start of reaction 2. After the worm time, add 9 of 30 aldehydes, and then add 3. Continue the insect time reaction. The reaction mixture is then cooled to -15 qo and 65 parts of magnesium sulfate and 219 parts of nickel peroxide are added and stirred at the same temperature for 30 minutes and then at room temperature for 40 minutes. The reactants were placed in a furnace, 5 parts of methanol was added to the furnace solution, and the mixture was heated at room temperature for 1. The period of time is cicada. The solvent was distilled off under reduced pressure, and the residue was passed through a silica gel column with 12 layers of silica gel and eluted with benzene-ethyl acetate (19:1) to obtain the desired 7-methoxy compound, 7B-(3.5
-di-t-butyl-4-hydroxybenzylidene)amino-3-chloro-7o-methoxy1-oxer1-dethia3-cephemu4-carboxylic acid p-nitrobenzyl ester (e: RI=CI; R2=COOCH2
C6 day 4・N02-p; 78 one side chain = 3.5-G t-
Butyl-4-hydroxybenzylidene amino) 125-9 (yield 52.2%) is obtained as a candy-like substance. IR
:〃Kinkan 3 arcs: 178o, 1735, 1680, 15
20, 1345. NMR: 6 (CDC13) Chest: 1.
48 (s, 1 group), 3.61 (s, thin), 4.49 (s
, is), 5.23 (s, IH), 5.44 (aromatic ring proton), 8.53 (s, IH). ■ The above 7-methoxy form (e: RI=CI; R2=COOCH2・C6day4・
N021p; 78 one side chain = 3,5-di-t-butyl-4
-Hydroxybenzylidene amino) 125 female was dissolved in a mixture of 2.5 parts of methanol and 0.5 parts of tetrahydrofuran, and added with Girard reagent (0jrard T).
Add 9 of 81 and stir at room temperature for 1 hour. The reaction mixture was poured into water, extracted with methylene chloride, and the methylene chloride extract was washed with water, dried, and evaporated under reduced pressure. The resulting residue was passed through a column of 3.5 mL of silica gel, and benzene-ethyl acetate (4:
1) After elution fractionation, the desired 7-amino compound (1:RI=
CI; R2=COOCH2・C65・N021p:R3
=OC) 35M (yield 43-8%) is obtained. IR
:Re Toen and 3 skins: 1790, 1740, 1520, 1
350. NMR: 6 (CDC13) Yanagi: 1.83 (戊, が), 3.53 (s, thin), 4.54 (s, ban), 5
.. 01 (s, IH), 5.47 (split, ga), 7
.. 67 (d, J = 9 days 2, IH), 8.28 (d, J:
9th day 2, IH), 8.28 (d, J=9HZ, IH).
Similarly, the following compounds can be obtained by any of the above methods.
78−アミノー1ーオキサー1−デチア−3−セフェム
ー4ーカルボン酸・p−ニトロベンジルエステル(1:
RIニH;R2=COOCH2・C6日・N02−p;
R3=H):(IR:レ鴇暖3肌‐1:3405、17
72、1726、1633、1605、1517、13
450NMR:6(CDCl3)肌:1.74(b、2
H)、4.61(m、2H)、5.05(d、1=4.
0HZ、IH)、5.42(広、2H)、5.5(m、
IH)、6.615(m、IH)、7.67および8.
31(q、J=9.0HZ、4H)。78-amino-1-oxa-1-dethia-3-cephemu 4-carboxylic acid p-nitrobenzyl ester (1:
RI NiH; R2=COOCH2・C6 day・N02-p;
R3=H): (IR:Retokudan 3hada-1:3405, 17
72, 1726, 1633, 1605, 1517, 13
450NMR: 6 (CDCl3) Skin: 1.74 (b, 2
H), 4.61 (m, 2H), 5.05 (d, 1=4.
0HZ, IH), 5.42 (wide, 2H), 5.5 (m,
IH), 6.615 (m, IH), 7.67 and 8.
31 (q, J=9.0HZ, 4H).
73ーアミノ−3ーメチルスルホニルオキシ−1ーオキ
サー1ーデチアー3ーセフエムー4ーカルボン酸・pー
ニトロベンジルェステル0 (1:RI=OS02CH
3:R2=COOCH2・C6日・N02‐p;R3:
H):IR:レ鍋係狐−・:342o、1790、17
35、16100NMR:6(CDC13)肌:2.1
5(戊、が)、3.23(s、細)、4,52(s、2
H)、5.02(d、J=4HZ、IH)、5.30(
s、が)、5.33(m、IH)、7.48および81
0(q、J=8.0HZ、4H)。73-Amino-3-methylsulfonyloxy-1-oxa-1-dethia-3-cephemu-4-carboxylic acid p-nitrobenzyl ester 0 (1:RI=OS02CH
3:R2=COOCH2・C6day・N02-p;R3:
H):IR:Renabe Kankitsune-・:342o, 1790, 17
35, 16100NMR: 6 (CDC13) Skin: 2.1
5 (戊, が), 3.23 (s, thin), 4,52 (s, 2
H), 5.02 (d, J=4HZ, IH), 5.30 (
s, ga), 5.33 (m, IH), 7.48 and 81
0 (q, J=8.0HZ, 4H).
78−アミノ−3ーフエニルチオ−1−オキサー1ーデ
チアー3−セフエムー4ーカルボン酸(1:RI=S・
Ph;R2=COOH;R3=H)。78-Amino-3-phenylthio-1-oxa-1-dethia-3-cefemu-4-carboxylic acid (1:RI=S.
Ph; R2=COOH; R3=H).
実施例 6‘1} 2一〔2f一(2ープロピニルオキ
シ)一38−アミノ−4ーオキソアゼチジン−1ーイル
〕−2ーィソプロピリデン酢酸・ジフェニルメチルエス
テル(2:R′ニCHPh2)−2一(2fークロルー
38ーアミノー4−オキソアゼチジン−1−ィル)−2
ーィソプロピリデン酢酸・ジフェニルメチルェステル(
1:R=CHPh2:X′=CI)0.95夕をプロパ
ルギルアルコール3の‘とテトラヒドロフラン2の‘の
混液にとかし、これにテトラフルオロ棚酸銀0.79夕
(4のmole)を加え、室温で3時間蝿拝する。Example 6'1} 2-[2f-(2-propynyloxy)-38-amino-4-oxoazetidin-1-yl]-2-isopropylideneacetic acid diphenylmethyl ester (2:R'-CHPh2 )-2-(2f-chloro-38-amino-4-oxoazetidin-1-yl)-2
-isopropylidene acetic acid diphenylmethyl ester (
1:R=CHPh2:X'=CI) 0.95 moles were dissolved in a mixture of 3 parts of propargyl alcohol and 2 parts of tetrahydrofuran, and 0.79 parts of silver tetrafluorochloride (4 moles) was added to this. Stir for 3 hours at room temperature.
反応混合物をベンゼン50叫で稀釈し、0℃に冷却して
、これに5%炭酸水素ナトリウム水10私と飽和食塩水
5の上との混液を加え櫨拝する。この混合物をセラィト
を通して炉過し、炉液を分離する。ベンゼン層を苧硝乾
燥し、減圧下に濃縮すると褐色油状物が得られる。これ
を10%含水シリカゲルを用いてのクロマトグラフィー
により精製すると、ベンゼン−酢酸エチル(1:1)混
液の画分から目的の2さ−プロピルオキシ誘導体(2:
R′=CHPh2)268の9(2Qープロピニルオキ
シ体134奴9および28−プロピニルオキシ体134
のo)が得られる。瀦ープロピニルォキシ体:IR:レ
視暖3弧「:3400、3320、2115、1767
、17230NMR:6(CDCl3)跡:1.83(
br‐s、汎)、1.98(s、知日)、2,22(s
、汎)、2.33(t、J=2.5HZ、IH)、4,
07(d、J=2.5日2、が)、約4.07(m、I
H)、4.93(d、J=1.0HZ、IH)、6.9
0(s、IH)、7.32(s、1順)23‐フ。The reaction mixture was diluted with 50 parts of benzene, cooled to 0°C, and a mixture of 10 parts of 5% sodium bicarbonate and 5 parts of saturated saline was added thereto. This mixture is filtered through Celite to separate the furnace liquor. The benzene layer is dried with ramie and concentrated under reduced pressure to yield a brown oil. When this was purified by chromatography using 10% hydrous silica gel, the desired 2-propyloxy derivative (2:
R'=CHPh2) 268 9 (2Q-propynyloxy form 134 members 9 and 28-propynyloxy form 134
o) is obtained. - Propynyloxy form: IR: 3400, 3320, 2115, 1767
, 17230NMR: 6 (CDCl3) trace: 1.83 (
br-s, general), 1.98 (s, chichi), 2,22 (s
, Pan), 2.33 (t, J=2.5HZ, IH), 4,
07 (d, J = 2.5 days 2, ga), about 4.07 (m, I
H), 4.93 (d, J=1.0HZ, IH), 6.9
0 (s, IH), 7.32 (s, 1 order) 23-F.
oピルォキシ体IR:ひ錦紫ム伽−,:3410、33
20、2115、1767、1720。NMR:6(C
DCl3)胸:1,77(br−s、2H)、2,00
(s、汎)、2.23(s、汎)、2.27(t、J=
2.5HZ、IH)、4.12(d、J=2.5HZ、
汎)、4.23(d、1:4.0HZ、IH)、5.2
7(d、J=4HZ、IH)、6.90(s、IH)、
7,32(s、1雌)。{2) 2−〔28一(2ープ
ロピニルオキシ)一38ーベンジルオキシカルボニルア
ミノー4ーオキソアゼチジンー1ーイル〕一2−イソプ
ロピリデン酢酸・ジフェニルメチルェステル(3:R=
PhC比OCO;R′=CHPh2)−上記28ープロ
ピニルオキシ誘導体(2:R′=CHPh2)30.0
夕(0.074mole)を無水塩化メチレン250の
【‘ことかし、これに氷冷下ペンジルオキシカルボニル
クロリド14.07夕(0.0825mole)を加え
、次いでこれにピリジン6.7の【(0.0828ho
le)と塩化メチレンからなる溶液を滴下し、袷時30
分間縄梓する。反応液を氷水中に注ぎ、塩化メチレンで
抽出し、抽出液を水、食塩水で洗浄、乾燥して、溶媒減
圧蟹去する。得られる油状残澄をシリカゲル1000夕
を使用してのクロマトグラフィーに付し、ベンゼン−酢
酸エチル(5:1)で溶出すると、26.5夕(66.
3%収率)の目的物38ーベンジルオキシカルボニルア
ミノ誘導体(3:R=PhC広OCO;R′=CHPh
2)が得られる。IR:レ落球〆3肌‐1:3440、
3300・2110・1774、1720、1630、
1507。NMR:6(CDC13)肌:2.00およ
び2.25(s、粗x2)、2.17(d、J=3HZ
、IH)、4.07(d、J=3日2、2H)、5.1
0(d、J=4HZ、IH)、5.17(s、が)、5
.33(q、J=8および4HZ、IH)、5.55(
d、J=8HZ、IH)、6.98(s、IH)。‘3
’ 2−(28−アリルオキシ−38−ペンジルオキシ
カルボニルアミノー4−オキソアゼチジン−1ーィル)
一2ーィソプロピリデン酢酸・ジフエニルメチルエステ
ル(4:R=PhCH20CO;R′=CHPh2)一
5%パラジウム−炭酸カルシウム6.6夕をメタノ」ル
170m‘に懸濁し、渡洋下に水素ガスを吸収させる。o Pyroxy form IR: Hikinishiki Muga-,: 3410, 33
20, 2115, 1767, 1720. NMR: 6(C
DCl3) Chest: 1,77 (br-s, 2H), 2,00
(s, general), 2.23 (s, general), 2.27 (t, J=
2.5HZ, IH), 4.12(d, J=2.5HZ,
Pan), 4.23 (d, 1:4.0HZ, IH), 5.2
7 (d, J=4HZ, IH), 6.90 (s, IH),
7,32 (s, 1 female). {2) 2-[28-(2-propynyloxy)-38-benzyloxycarbonylamino-4-oxoazetidin-1-yl]-2-isopropylideneacetic acid diphenylmethyl ester (3:R=
PhC ratio OCO; R'=CHPh2) - the above 28-propynyloxy derivative (2:R'=CHPh2) 30.0
0.074 mole of anhydrous methylene chloride was added to 250 moles of anhydrous methylene chloride, 14.07 mole of penzyloxycarbonyl chloride (0.0825 mole) was added under ice-cooling, and then 6.7 moles of pyridine was added to the solution of 6.7 mole of pyridine. 0.0828ho
A solution consisting of methylene chloride and methylene chloride was added dropwise, and the
Rope for a minute. The reaction mixture was poured into ice water and extracted with methylene chloride. The extract was washed with water and brine, dried, and the solvent was removed under reduced pressure. The resulting oily residue was chromatographed on silica gel 1000 ml and eluted with benzene-ethyl acetate (5:1) to yield 26.5 ml (66.5 ml).
3% yield) of the target product 38-benzyloxycarbonylamino derivative (3: R = PhC wide OCO; R' = CHPh
2) is obtained. IR:Re falling ball 〆3 skin-1:3440,
3300・2110・1774, 1720, 1630,
1507. NMR: 6 (CDC13) Skin: 2.00 and 2.25 (s, coarse x2), 2.17 (d, J=3HZ
, IH), 4.07 (d, J = 3 days 2, 2H), 5.1
0 (d, J=4HZ, IH), 5.17 (s, ga), 5
.. 33 (q, J=8 and 4HZ, IH), 5.55 (
d, J=8HZ, IH), 6.98 (s, IH). '3
'2-(28-allyloxy-38-penzyloxycarbonylamino-4-oxoazetidin-1yl)
12-isopropylidene acetic acid/diphenyl methyl ester (4:R=PhCH20CO;R'=CHPh2) 15% palladium-calcium carbonate was suspended in 170m' of methanol and hydrogenated under the ocean. absorb gas.
次いで上記38−ペンジルオキシカルボニルアミノ誘導
体(3:R=PhCH20CO:R′=CHPh2)2
6.5夕(0.049hole)をメタノール100叫
にとかして、パラジウム触媒懸濁液に加える。水素ガス
中50分間燭拝した後、触媒を炉去し、炉液を減圧濃縮
すると、目的の28ーアリルオキシ誘導体(4:R=P
hCH20CO;R′=CHPh2)26.3夕(98
.8%収率)が得られる。IR:レ鴇袋と3肌‐1:私
40、1772、172止 1628、1505。NM
R:6(CDCl3)跡:2.00および2,25(s
、がx2)、3‐90(m、2H)、4.8〜5‐9(
m、母H)、5.17(s、が)、6.95(s、IH
)。■2−〔28一(2・3ーエポキシプロポキシ)−
33ーベンジルオキシカルボニルアミノー4ーオキソア
ゼチジンー1ーイル〕‐2−イソプ。ピリデン酢酸・ジ
フェニルメチルェステル(5:R=PhC比OCO:R
′工CHPh2)−上記28ーアリルオキシ誘導体(4
:R=PhC&OCO ;R′ = CHPQ )25
.6 夕(0.047mole)をクロロホルム260
の‘にとかし、これにm−クロル過安息香酸15.3夕
(0.071mole)を徐々に加え、室温(23〜2
5q0)にて2自問放置する。Then, the above 38-penzyloxycarbonylamino derivative (3:R=PhCH20CO:R'=CHPh2)2
Dissolve 0.049 holes in 100 ml of methanol and add to the palladium catalyst suspension. After standing in hydrogen gas for 50 minutes, the catalyst was removed from the furnace and the furnace liquid was concentrated under reduced pressure to obtain the desired 28-allyloxy derivative (4:R=P
hCH20CO; R'=CHPh2) 26.3 evening (98
.. 8% yield) is obtained. IR: Le Tokibukuro to 3hada-1: I 40, 1772, 172 stops 1628, 1505. N.M.
R: 6 (CDCl3) Trace: 2.00 and 2,25 (s
, is x2), 3-90 (m, 2H), 4.8-5-9 (
m, mother H), 5.17 (s, ga), 6.95 (s, IH
). ■2-[28-(2.3-epoxypropoxy)-
33-benzyloxycarbonylamino-4-oxoazetidin-1-yl]-2-isop. Pyrideneacetic acid/diphenylmethyl ester (5:R=PhC ratio OCO:R
'CHPh2) - the above 28-allyloxy derivative (4
:R=PhC&OCO;R'=CHPQ)25
.. 6 Add 0.047 mole of chloroform to 260
To this, 15.3 moles (0.071 mole) of m-chloroperbenzoic acid was gradually added, and the mixture was heated to room temperature (23 to 2 moles).
Leave 2 questions to yourself at 5q0).
反応液を減圧濃縮し、得られる残湾を酢酸エチルにとか
し、5%チオ硫酸ナトリウム水、5%炭酸水素ナトリウ
ム水、水、および食塩水で順次洗浄し、溶媒を減圧蟹去
する。得られる油状残澄をシリカゲル800夕を用いて
のクロマトグラフィーに付し、ベンゼン−酢酸エチル(
5:1)で熔出すると、目的のェポキシ誘導体(5:R
=PhCH20CO;R=CHPh2)21.25夕(
81.2%収率)が得られる。IRI:び鴇鞍3肌‐1
:3445、1778・1724・1632、1508
。NMR:6(CDC13)柳:2.00および2.2
5(s、細x2)、約2.2〜3.9(m、斑)、5.
18(s、が)、約5.0〜5.3(m、2H)、5.
58(d、J=10日2、IH)、6.83(s、IH
)。なお、この工程では副生物として少量のジェポキシ
体(2.25夕;mpl18〜120oo)が得られる
。■ 2一〔28一(2・3ージヒドロキシプロポキシ
)−3ーベンジルオキシカルボニルアミノー4ーオキソ
アゼチジン−1ーイル〕一2−イソプロピリデン酢酸・
ジフェニルメチルェステル(6:R=PhC比OCO;
R′=CHPh2)一上記ェポキシ誘導体(5:R=P
hC比OCO:R′=CHPh2)21.25夕(0.
038hole)をアセトン220M‘にとかし、これ
に30%過塩素酸66の【および水44机上を氷冷下に
加え、室温で2〜3時間燈梓する。The reaction solution is concentrated under reduced pressure, and the resulting residue is dissolved in ethyl acetate, washed successively with 5% aqueous sodium thiosulfate, 5% aqueous sodium bicarbonate, water, and brine, and the solvent is removed under reduced pressure. The resulting oily residue was chromatographed on silica gel 800 gel and benzene-ethyl acetate (
5:1), the desired epoxy derivative (5:R
=PhCH20CO; R=CHPh2) 21.25 evening (
81.2% yield) is obtained. IRI: Bitokura 3 Hada-1
:3445, 1778/1724/1632, 1508
. NMR: 6 (CDC13) Yanagi: 2.00 and 2.2
5 (s, thin x 2), about 2.2-3.9 (m, mottled), 5.
18 (s, ga), about 5.0-5.3 (m, 2H), 5.
58 (d, J = 10 days 2, IH), 6.83 (s, IH
). In addition, in this step, a small amount of jepoxy body (2.25 min; mpl 18-120 oo) is obtained as a by-product. ■ 2-[28-(2,3-dihydroxypropoxy)-3-benzyloxycarbonylamino-4-oxoazetidin-1-yl]-2-isopropylideneacetic acid.
Diphenylmethyl ester (6:R=PhC ratio OCO;
R′=CHPh2) The above epoxy derivative (5:R=P
hC ratio OCO: R' = CHPh2) 21.25 evening (0.
038hole) is dissolved in 220M' of acetone, 66% of 30% perchloric acid and 44ml of water are added thereto under ice-cooling, and the mixture is heated at room temperature for 2 to 3 hours.
反応液に酢酸エチルを加え、5%炭酸水素ナトリウム水
、水、および食塩水で順次洗浄した後、溶媒を減圧蟹去
する。得られる油状残澄をメタノール200地にとかし
、10%塩酸40泌を加え室温で30分間燈梓する。次
いで酢酸エチルを加え、5%炭酸水素ナトリウム水、水
、および食塩水で洗浄、乾燥後、溶媒を減圧蟹去すると
、目的のジオール誘導体(6:R=PhC比OCO;R
′=CHPh2)20.6夕(94.4%収率)が得ら
れる。Ethyl acetate was added to the reaction mixture, and the mixture was washed successively with 5% aqueous sodium bicarbonate, water, and brine, and then the solvent was removed under reduced pressure. The resulting oily residue was dissolved in 200% methanol, added with 40% 10% hydrochloric acid, and stirred at room temperature for 30 minutes. Next, ethyl acetate was added, washed with 5% sodium bicarbonate solution, water, and brine, and after drying, the solvent was removed under reduced pressure to obtain the desired diol derivative (6:R=PhC ratio OCO;R
'=CHPh2) 20.6 hours (94.4% yield) are obtained.
IR:レ鴇暖3伽−・:36oo、3445、1778
、1725、1632、1508。NMR:6(CDC
13)胸:1.97および2.22(s、汎x2)、3
.47(m、4H)、4.9〜5.3(m、2H)、5
.13(s、が)、6.07(m、IH)、6.97(
s、IH)。同様にして上記28−プロピニルオキシ体
(2:R=CHPh2)をフエニルアセチルクロリドと
反応させて33一フェニルアセトァミド誘導体(3:R
=PhCはOCO;R′=CHPh2)とし、これを順
次、水素化、ェポキシ化、ェポキシ関環工程に付すと、
2−〔26−(2・3−ジヒドロキシプロポキシ)−3
8−フエニルアセトアミド一4ーオキソアゼチジンー1
−イル〕−2−ィソプロピリデン酢酸・ジフェニルメチ
ルェステル(6:R=PhCQCO;R′=CHPh2
)が得られる。IR: 36oo, 3445, 1778
, 1725, 1632, 1508. NMR: 6 (CDC
13) Chest: 1.97 and 2.22 (s, pan x2), 3
.. 47 (m, 4H), 4.9-5.3 (m, 2H), 5
.. 13 (s, ga), 6.07 (m, IH), 6.97 (
s, IH). Similarly, the above 28-propynyloxy compound (2:R=CHPh2) was reacted with phenylacetyl chloride to obtain a 33-phenylacetamide derivative (3:R=CHPh2).
=PhC is OCO; R'=CHPh2), and when this is sequentially subjected to hydrogenation, epoxidation, and epoxy ring process,
2-[26-(2,3-dihydroxypropoxy)-3
8-phenylacetamido-4-oxoazetidine-1
-yl]-2-isopropylideneacetic acid diphenylmethyl ester (6: R=PhCQCO; R'=CHPh2
) is obtained.
実施例 7
{1’2−〔28−(2・3−イソプロピリデンジオキ
シプロポキシ)一38−ペンジルオキシカルポニルアミ
ノ−4−オキソアゼチジン−1−ィル〕−2ーィソプロ
ピリデン酢酸・ジフェニルメチルエステル(13:R=
PhCH20CO;R′一CHPh2)一2一〔28一
(2.3ージヒドロキシプロポキシ)−38−ペンジル
オキシカルボニルアミノ−4ーオキソアゼチジン−1ー
ィル〕−2−イソプロピリデン酢酸・ジフェニルメチル
ヱステル(6:R=PhCH20CO;R=CHPh2
)2.5夕をアセトン50Mにとかし、これにpートル
ェご/スルホン酸5の9を氷冷下に加えて、3時間凝拝
する。Example 7 {1'2-[28-(2,3-isopropylidenedioxypropoxy)-38-penzyloxycarponylamino-4-oxoazetidin-1-yl]-2-isopropylideneacetic acid diphenyl Methyl ester (13:R=
PhCH20CO; R'-CHPh2)-28-(2,3-dihydroxypropoxy)-38-penzyloxycarbonylamino-4-oxoazetidin-1-yl]-2-isopropylideneacetic acid diphenylmethylester (6: R=PhCH20CO; R=CHPh2
) Dissolve 2.5 liters in 50M acetone, add 5 parts 9 parts of p-toluene/sulfonic acid to this under ice cooling, and stir for 3 hours.
次いで、これに5%炭酸水素ナトリウム水少量を加えて
減圧濃縮する。残湾を酢酸エチルにとかし、水洗、乾燥
、濃縮して得られる残湾をシリカゲルによるクロマトグ
ラフィーに付して、ベンゼン−酢酸エチル(2:1)で
溶出すると、目的のィソプロピリデンジオキシ譲導体(
13:R=PhC比OCO:R′=CHPh2)2.2
6夕(84%収率)が得られる。Next, a small amount of 5% aqueous sodium hydrogen carbonate is added to this, and the mixture is concentrated under reduced pressure. The remaining residue was dissolved in ethyl acetate, washed with water, dried, and concentrated. The obtained residue was subjected to chromatography on silica gel and eluted with benzene-ethyl acetate (2:1) to obtain the desired isopropylidene dioxy Conductor (
13: R = PhC ratio OCO: R' = CHPh2) 2.2
6 hours (84% yield) are obtained.
IR:レ鴇隊3肌‐1:3450、1780、1725
、1635、1600。NMR: 6(CDC13)脚
;1.28(s、細)、2.00(s、汎)、2.25
(s、3H)、3.25〜4.20(m、斑)、4.9
0〜5.77(m、斑)、6.95(s、IH)、7.
3付近(m、1班)。(2手 2−〔28−(2・3ー
イソプロピリデンジオキシプロポキシ)−38ーベンジ
ルオキシカルボニルアミノ−4−オキソアゼチジンー1
−ィル〕−2ーヒドロキシ酢酸・ジフェニルメチルエス
テル(15:RニPhCH20CO;R′;CHPh2
)−上記ィソプロピリデンジオキシ誘導体(13:R=
PhC拡OCO:R′=CHPh2)2.2夕(3.5
8mmole)を塩化メチレン40の上にとかし、これ
に、ドライアイスーァセトン冷却下、反応液が青色を呈
するまでオゾンを導適する。IR: Retotai 3hada-1:3450, 1780, 1725
, 1635, 1600. NMR: 6 (CDC13) legs; 1.28 (s, thin), 2.00 (s, wide), 2.25
(s, 3H), 3.25-4.20 (m, spots), 4.9
0-5.77 (m, spots), 6.95 (s, IH), 7.
Around 3 (m, 1 group). (2 hands 2-[28-(2,3-isopropylidenedioxypropoxy)-38-benzyloxycarbonylamino-4-oxoazetidine-1
-yl]-2-hydroxyacetic acid diphenylmethyl ester (15:RPhCH20CO;R';CHPh2
)-the above isopropylidene dioxy derivative (13:R=
PhC expansion OCO: R'=CHPh2) 2.2 evenings (3.5
8 mmole) was dissolved over 40 methylene chloride, and ozone was introduced therein under cooling with dry ice-acetone until the reaction solution took on a blue color.
過剰のオゾンを除いた後、硫化メチル2.2の‘を加え
て同温冷却下に1時間、更に室温に1時間放置する。反
応液に少量の酢酸を加えた後、水洗、乾燥、濃縮すると
、中間体としての1ージフェニルメトキサリル−28−
(2・3ーイソプロピリデンジオキシプロポキシ)一3
8ーベンジルオキシカルボニルアミノー4−オキソアゼ
チジン(14:R=PhC止OCO:R=CHPh2)
2夕が得られる。これを直ちに塩化メチレン20の上と
酢酸20の‘との源液にとかし、活性化亜鉛末2夕を加
えて、氷袷下に2時間鷹拝する。亜鉛末を炉去し、塩化
メチレンで洗浄、炉液および洗液を合せて水洗、乾燥、
濃縮すると、目的の2−ヒドロキシ誘導体(15:R=
PhCH20CO;R′=CHPh2)2.0夕(95
%収率)が得られる。IR:し楓静肌4:350o、3
43o・1780・1740・1720、16000N
MR:6(CDC13)肌:1.47(s、細)、3.
17〜4.30(m、5〜細)、5.16(s、汎)、
4.70〜6.00(m、3〜4H)、6.97および
7.00(各s、IH)、7.針寸近(m、芳香環プロ
トン)。(3’2−〔28一(2・3−イソプロピリデ
ンジオキシプロポキシ)−38ーベンジルオキシカルボ
ニルアミノ−4−オキソアゼチジンー1ーィル〕−2−
トリフェニルホスホラニリデン酢酸・ジフェニルメチル
ェステル(16:R=PhC比OCO;R′=CHPh
2)−上記2−ヒドロキシ譲導体(15:R=PhCH
20CO;R′=CHPh2)2.0夕(3.4mmo
le)を無水塩化メチレン60の‘にとかし、これにジ
メチルアニリン1.3のと(10.2のmole)を氷
冷下に加えた後、塩化チオニル0.74の‘(10.2
mmole)を滴下し、同温度に30分間鷹柊する。After removing excess ozone, 2.2 g of methyl sulfide was added, and the mixture was cooled at the same temperature for 1 hour and then left at room temperature for 1 hour. After adding a small amount of acetic acid to the reaction solution, washing with water, drying, and concentrating, the intermediate 1-diphenylmethoxalyl-28-
(2,3-isopropylidenedioxypropoxy)-3
8-benzyloxycarbonylamino-4-oxoazetidine (14:R=PhC-OCO:R=CHPh2)
You get 2 evenings. Immediately dissolve this in a source solution of 20 parts methylene chloride and 20 parts acetic acid, add 2 parts activated zinc powder, and keep under ice for 2 hours. Remove the zinc powder in a furnace, wash with methylene chloride, combine the furnace liquid and washing liquid, wash with water, dry,
Upon concentration, the desired 2-hydroxy derivative (15:R=
PhCH20CO; R'=CHPh2) 2.0 evening (95
% yield) is obtained. IR: Shikaede Shizuhada 4: 350o, 3
43o・1780・1740・1720, 16000N
MR: 6 (CDC13) Skin: 1.47 (s, thin), 3.
17-4.30 (m, 5-thin), 5.16 (s, wide),
4.70-6.00 (m, 3-4H), 6.97 and 7.00 (each s, IH), 7. Close to the needle (m, aromatic ring proton). (3'2-[28-(2,3-isopropylidenedioxypropoxy)-38-benzyloxycarbonylamino-4-oxoazetidin-1-yl]-2-
Triphenylphosphoranylidene acetic acid/diphenylmethyl ester (16: R=PhC ratio OCO; R'=CHPh
2)-The above 2-hydroxy transferor (15:R=PhCH
20CO; R'=CHPh2) 2.0 evening (3.4 mmo
Le) was dissolved in 60' of anhydrous methylene chloride, 1.3 mole of dimethylaniline (10.2 mole) was added thereto under ice cooling, and then 0.74 mole of thionyl chloride (10.2 mole) was dissolved.
mmole) was added dropwise and kept at the same temperature for 30 minutes.
反応液を氷冷中にあげ、塩化メチレン層を水洗、乾燥し
て濃縮すると、中間体としての2一〔23一(2・3ー
ィソプロピリデンジオキシプoポキシ)−38ーベンジ
ルオキシカルボニルアミノー4−オキソアゼチジン−1
−ィル〕‐2ークロル酢酸・ジフェニルメチルェステル
2.3夕が得られる〔IR:レ錦塩〆」仇‐1:343
01178ふ1750・1720・1595〕にれを塩
化メチレン40の‘にとかし、これにジメチルアニリン
0.86泌(6.8のmole)およびトリフエニルホ
スフイン1.89(6.8mmole)を加え、6時間
加熱還流した後、更にトリフェニルホスフィン1.8夕
を追加して、12時間反応させる。反応混合物を5%炭
酸水素ナトリウム水に冷却下注ぎ、水洗、乾燥、濃縮す
る。得られる残澄をシリカゲルによるクロマトグラフィ
ーに付すと、目的のトリフェニルホスホラン誘導体(1
6:REPhC拡OCO:R′=CHPh2)1.6夕
(56.6%収率)が得られる。The reaction solution was cooled with ice, and the methylene chloride layer was washed with water, dried, and concentrated to give 2-[23-(2,3-isopropylidenedioxypropoxy)-38-benzyloxy] as an intermediate. Carbonylamino-4-oxoazetidine-1
-Yel]-2-chloroacetic acid diphenylmethyl ester 2.3 times is obtained [IR:Renishikishio〆]2-1:343
01178F1750/1720/1595] Dissolve garlic in 40% methylene chloride, add 0.86 dimethylaniline (6.8 mole) and 1.89 (6.8 mmole) of triphenylphosphine, After heating under reflux for 6 hours, 1.8 hours of triphenylphosphine was added and the mixture was allowed to react for 12 hours. The reaction mixture was poured into 5% sodium bicarbonate water under cooling, washed with water, dried, and concentrated. The resulting residue was subjected to chromatography on silica gel to obtain the desired triphenylphosphorane derivative (1
6: REPhC expanded OCO: R'=CHPh2) 1.6 hours (56.6% yield) is obtained.
IR:レ錦袋3伽‐1:3400、1760、1710
、1620、1590。{4ー 2一〔23一(2・3
ージヒドロプロポキシ)−38−ペンジルオキシカルボ
ニルアミノ−4−オキソアゼチジン−1ーイル〕−2ー
トリフヱニルホスホラニリデン酢酸・ジフェニルメチル
エステル(17:R=PhCH20CO;R′=CHP
h2)−上記トリフェニルホスホラン誘導体(16:R
=PhCH20CO;R′=CHPh2)417m9(
0.5mmole)をメタノール8の‘にとかし、これ
に10%塩酸1.6泌を加え、室温で40分間蝿拝する
。反応液を冷却した5%炭酸水素ナトリウム水にあげ、
酢酸エチルで抽出する。抽出液を水洗、乾燥、濃縮して
得られる残溶をシリカゲルによるクロマトグラフィーに
付すと、目的の脱アセトニド体(17:R=PhC広O
CO:R′=CHPh2)172の9(43.3%収率
)が得られる。IR三レ錦舷3肌‐1:3450〜32
00、1770・1720・1630、1600。‘5
)78−ペンジルオキシカルボニルアミノ−1−オキサ
−1ーデチア−3ーセフエム−4ーカルボン酸・ジフェ
ニルメチルェステル(W:RこPhCH20CO;R′
=CHPh2)−上記脱アセトニド体(i7:R=Ph
CH20CO;R′=CHPh2)139雌(0.17
5mmole)をテトラヒドロフラン4の{にとかし、
これに過ヨウ素酸(Nal0445の9およびIN一W
S042.2の【より成る)を氷冷下に加え、同温度で
3時間櫨梓後、更に室温で1時間燈梓する。IR: Les Nishikibukuro 3-1: 3400, 1760, 1710
, 1620, 1590. {4-21 [231 (2.3
-dihydropropoxy)-38-penzyloxycarbonylamino-4-oxoazetidin-1-yl]-2 triphenylphosphoranylidene acetic acid diphenylmethyl ester (17: R=PhCH20CO; R'=CHP
h2) - the above triphenylphosphorane derivative (16:R
=PhCH20CO;R'=CHPh2)417m9(
Dissolve 0.5 mmole in 8 parts of methanol, add 1.6 parts of 10% hydrochloric acid, and stir at room temperature for 40 minutes. The reaction solution was poured into cooled 5% sodium hydrogen carbonate water,
Extract with ethyl acetate. The extract was washed with water, dried, and concentrated, and the resulting residual solution was subjected to chromatography on silica gel to obtain the desired deacetonide (17:R=PhC
CO:R'=CHPh2) 9 of 172 (43.3% yield) is obtained. IR Sanre Kinka 3 Hada-1:3450-32
00, 1770/1720/1630, 1600. '5
) 78-penzyloxycarbonylamino-1-oxa-1-dethia-3-cephem-4-carboxylic acid diphenylmethyl ester (W:RPhCH20CO;R'
=CHPh2)-the above deacetonide form (i7:R=Ph
CH20CO; R'=CHPh2) 139 female (0.17
5 mmole) in 4 parts of tetrahydrofuran,
This was added to periodic acid (9 of Nal0445 and IN-W).
S042.2 (consisting of) was added under ice cooling, and the mixture was incubated at the same temperature for 3 hours, and then further incubated at room temperature for 1 hour.
反応混合物を氷水にあげ、酢酸エチルで抽出し、抽出液
を水洗、乾燥、濃縮して得られる残澄をシリカゲルのク
ロマトグラフィーにより分離精製すると、目的のオキサ
セフェム保護置換誘導体(W:R=PhC山OCO:R
′=CHPh2)15の9(17.7%収率)が得られ
る。本品は実施例2で得られる別途合成品と、薄層クロ
マトグラフイ−、IRスペクトル、NM旧スペクトルに
おいて完全に一致し、同一化合物であることが確認でき
る。実施例 8
{1) 2−〔28一(2ーオキソエチルオキシ)−3
8ーベンジルオキシカルボニルアミノー4−オキソアゼ
チジンー1−イル〕一2ーイソプロピリデン酢酸・ジフ
ェニルメチルヱステル(7:R=PhCH20CO;R
′=CHPh2)−2−〔26一(2・3−ジヒドロキ
シプロポキシ)一38ーベンジルオキシカルボニルアミ
ノー4ーオキソアゼチジンー1ーイル〕一2−イソプロ
ピリデン酢酸・ジフェニルメチルェステル(6:R=P
hCH20CO;R′=CHPh2)11.5夕(0.
02hole)をエタノール200の‘にとかし、これ
に過ヨウ素酸ナトリウム5.14夕(0.024mol
e)とIN−硫酸210の‘からなる溶液を加え、室温
で3粉ご間鷹拝する。The reaction mixture was poured into ice water and extracted with ethyl acetate. The extract was washed with water, dried, and concentrated. The resulting residue was separated and purified by silica gel chromatography to obtain the desired oxacephem protected substituted derivative (W:R=PhC Mountain OCO:R
'=CHPh2) 9 of 15 (17.7% yield) is obtained. This product completely matches the separately synthesized product obtained in Example 2 in thin layer chromatography, IR spectrum, and NM old spectrum, confirming that it is the same compound. Example 8 {1) 2-[28-(2-oxoethyloxy)-3
8-benzyloxycarbonylamino-4-oxoazetidin-1-yl]-2-isopropylideneacetic acid diphenylmethylester (7:R=PhCH20CO;R
'=CHPh2)-2-[26-(2,3-dihydroxypropoxy)-38-benzyloxycarbonylamino-4-oxoazetidin-1-yl]-2-isopropylideneacetic acid diphenylmethyl ester (6:R =P
hCH20CO; R'=CHPh2) 11.5 evening (0.
02hole) was dissolved in 200ml of ethanol, and to this was added 5.14ml of sodium periodate (0.024mol).
Add a solution consisting of e) and IN-sulfuric acid 210' and mix for 3 minutes at room temperature.
反応液を氷水中に注ぎ、酢酸エチルで抽出、抽出液を水
および食塩水で洗浄し、乾燥後溶媒を減圧下留去すると
、目的のホルミル謙導体(7:R=PhC&OCO:R
′=C肝h2)lo.8タカミ得られる。IR:レ鴇舞
ム仇1:344ふ1778172ふ1632、150&
‘2) 2一(28−メトキシカルボニルメトキシー3
8ーベンジルオキシカルボニルアミノー4−オキソアゼ
チジン−1ーイル)一2−イソプロピリデン酢酸・ジフ
ヱニルメチルェステル(8:R=PhCH20CO:R
′=−CHPh2;R″=C比)上記ホルミル誘導体(
7:R=
PhC比OCO:R′=一CHPh2)10.8夕をア
セトン100肌にとかし、氷冷蝿投下にジョーンズ試薬
14Mを15qo以下の温度で加える。The reaction solution was poured into ice water, extracted with ethyl acetate, the extract was washed with water and brine, and after drying, the solvent was distilled off under reduced pressure to obtain the desired formyl conductor (7:R=PhC&OCO:R
' = C liver h2) lo. You can get 8 takami. IR:Res Tokimaimu 1:344fu1778172fu1632,150&
'2) 2-(28-methoxycarbonylmethoxy3
8-benzyloxycarbonylamino-4-oxoazetidin-1-yl)-2-isopropylideneacetic acid diphenylmethyl ester (8:R=PhCH20CO:R
'=-CHPh2;R''=C ratio) the above formyl derivative (
7:R=PhC ratio OCO:R'=1CHPh2) Dissolve 10.8 liters in 100 ml of acetone and add 14 M of Jones reagent at a temperature below 15 qo to an ice-cold drop.
30分経過後、反応液にiープロパノールを加えて過剰
の試薬を殺し、不溶物を炉去する。After 30 minutes, i-propanol is added to the reaction solution to kill excess reagent, and insoluble matter is removed in an oven.
炉液を氷水中に注ぎ、酢酸エチルで抽出し、抽出液を水
、.食塩水で洗浄後、溶媒を減圧留去すると、粗製のカ
ルボン酸(8:R=PhCH20CO;R′=CHP〜
;R″=H)11.1夕が得られる。これを塩化メチレ
ン150泌にとかし、ジアゾメタン−エーテル溶液を加
えてヱステル化する。溶媒を留去し、得られる残溝11
夕をシリカゲル200夕のカラムに通し、ベンゼン一酢
酸エチル(5:1)で溶出すると、目的のカルボン酸メ
チル(8:R=PhC止OCO;R′=CHPh2;R
″=C馬)9.2夕(80.3%収率)が得られる。I
R:し鴇塩そ肌‐1:344ぅ1780、172ふ16
35・15100NMR:6(CDC13)胸:2.0
0および2.25(各s、汎x2)、 3.58(s、
祖)、3.97(s、餌)、5.0〜5.40(m、が
)、5.13(s、汎)、5.57(d、J=8HZ、
IH)、6.93(s、IH)。{3’1ージフエニル
メトキサリル−28−メトキシカルボニルメトキシー3
8−ペンジルオキシカルボニルアミノー4ーオキソアゼ
チジン(9:R=PhCQOCO:R′=CHPh2;
R″=Cは)−上記カルボン酸メチル(8:R:PhC
比OCO:R′=CHPh2;R″=CH3)9.2夕
(0.016hole)を塩化メチレン230の‘にと
かし、−78q Cに冷却して、これにオゾンを導適す
る。The furnace solution was poured into ice water, extracted with ethyl acetate, and the extract was poured into water. After washing with brine, the solvent was distilled off under reduced pressure to obtain the crude carboxylic acid (8: R=PhCH20CO; R'=CHP~
R″=H) 11.1 is obtained. This is dissolved in 150 methylene chloride and esterified by adding a diazomethane-ether solution. The solvent is distilled off and the resulting residue 11
The sample was passed through a silica gel 200 column and eluted with benzene monoethyl acetate (5:1) to obtain the desired methyl carboxylate (8: R = PhC; R' = CHPh2; R
″=C horse) 9.2 days (80.3% yield) is obtained.I
R: Shitoshio Sohada - 1: 344 1780, 172 Fu 16
35.15100NMR: 6 (CDC13) Chest: 2.0
0 and 2.25 (each s, pan x2), 3.58 (s,
ancestor), 3.97 (s, bait), 5.0-5.40 (m, ga), 5.13 (s, general), 5.57 (d, J=8HZ,
IH), 6.93 (s, IH). {3'1-diphenylmethoxalyl-28-methoxycarbonylmethoxy 3
8-penzyloxycarbonylamino-4-oxoazetidine (9:R=PhCQOCO:R'=CHPh2;
R″=C is)-the above methyl carboxylate (8:R:PhC
The ratio OCO: R'=CHPh2;R''=CH3) 9.2 holes (0.016 holes) is dissolved in methylene chloride 230', cooled to -78q C and ozone introduced therein.
約3び分後、反応液が青色を呈したところで反応を止め
、窒素ガスを導通して過剰のオゾンを追い出す。次いで
一78『0に冷却してジメチルスルフィド10の‘を加
え、同温度で1時間、更に室温で1時間蝿拝する。反応
液に塩化メチレンおよび酢酸2〜3滴を加え、水、食塩
水で順次洗浄し、乾燥後、溶媒を留去すると目的のメト
キサリル誘導体(9:R=PhCH20CO;R′=C
HPh2;R″=CH3)8.99が油状物として得ら
れる。IR:レ錦隊3伽‐1:3450、1830・1
756・1720、1509。(4} 2−(28ーメ
トキシカルボニルメトキシ−38ーベンジルオキシカル
ボニルアミノー4ーオキソアゼチジンー1ーイル)一2
−ヒドロキシ酢酸・ジフェニルメチルェステル(10:
R=PhC均OCO;R′=CHPh2:R″=CH3
)−上記〆トキサリル誘導体(9:R=PhCH20C
O:R′iCHPh2:R″=CH3)8.9夕を塩化
メチレン90のとおよび酢酸90羽の混液にとかし、こ
れに活性亜鉛末9夕を氷冷鷹梓下に加える。After about 3 minutes, when the reaction solution turns blue, the reaction is stopped and nitrogen gas is introduced to drive out excess ozone. Then, the mixture was cooled to 178°C, 10°C of dimethyl sulfide was added, and the mixture was incubated at the same temperature for 1 hour and then at room temperature for 1 hour. 2 to 3 drops of methylene chloride and acetic acid were added to the reaction solution, washed successively with water and brine, dried, and the solvent was distilled off to obtain the desired methoxalyl derivative (9: R=PhCH20CO; R'=C
HPh2;R''=CH3) 8.99 is obtained as an oil.IR:Rekintai 3-1:3450, 1830.1
756, 1720, 1509. (4} 2-(28-methoxycarbonylmethoxy-38-benzyloxycarbonylamino-4-oxoazetidin-1-yl)-2
-Hydroxyacetic acid diphenylmethyl ester (10:
R=PhC uniform OCO; R′=CHPh2:R″=CH3
)-the above toxalyl derivative (9:R=PhCH20C
O:R'iCHPh2:R''=CH3) 8.9 hours was dissolved in a mixture of 90 parts of methylene chloride and 90 parts of acetic acid, and 9 parts of activated zinc powder was added to this under ice-cooled water.
約15〜30分経過後、亜鉛末を炉去し、炉液に塩化メ
チレンを追加して、水、食塩水で順次洗浄する。乾燥後
、溶媒を減圧留去すると、目的のヒドロキシ酢酸誘導体
(10:R=PhC比OCO;R′=CHPh2:R″
=CH3)8.4夕(95.2%収率)が得られる。I
R:レ錦髪3肌‐1:3500〜360以3445・1
790 1747、1512。【5’2−(20ーメト
キシカルポニルメトキシ−38−ペンジルオキシカルポ
ニルアミノー4ーオキソアゼチジンー1ーィル)−2ー
クロル酢酸・ジフェニルメチルェステル(il:R=P
hC比OCO:R′=CHPh2;R″=CH3;X′
′=CI)−上記ヒドロキシ酢酸譲導体(io:R=P
hC比OCO;R′=CHPh2:R″=CH3)8.
4夕(0.015mole)を無水塩化メチレン100
の‘にとかし、これに塩化チオニル3.34汎‘(0.
046mole)およびピリジン1.46机【(0.0
18mole)を氷冷縄洋下に滴下する。After about 15 to 30 minutes, the zinc powder is removed from the furnace, methylene chloride is added to the furnace solution, and the mixture is washed successively with water and saline. After drying, the solvent was distilled off under reduced pressure to obtain the desired hydroxyacetic acid derivative (10:R=PhC ratio OCO; R'=CHPh2:R''
=CH3) 8.4 hours (95.2% yield) are obtained. I
R: Leskin hair 3 skin-1: 3500-360 or more 3445.1
790 1747, 1512. [5'2-(20-Methoxycarponylmethoxy-38-penzyloxycarponylamino-4-oxoazetidin-1-yl)-2-chloroacetic acid diphenylmethyl ester (il:R=P
hC ratio OCO: R'=CHPh2;R''=CH3;X'
'=CI) - the above hydroxyacetic acid transfer derivative (io:R=P
hC ratio OCO; R'=CHPh2:R''=CH3)8.
4 moles (0.015 mole) of anhydrous methylene chloride 100
of thionyl chloride, and add 3.34% of thionyl chloride (0.
046 moles) and 1.46 moles of pyridine [(0.0
18 mole) was dropped onto an ice-cold rope underwater.
氷冷下に3び分間燭拝した後、反応液に適量の塩化メチ
レンを加え、水、食塩水で洗浄する。乾燥後、溶媒を減
圧留去すると、目的のモノクロル酢酸譲導体(11:R
=PhC比OCO;R′=CHPh2:R″=CH3;
〕″−CI)8.9夕が得られる。rw鶏皮3肌‐1:
3435、1790、1748、1725 1502。
{6’2−(28−力ルポキシメトキシ−30−ペンジ
ルオキシカルボニルアミノー4−オキソアゼチジン−1
ーイル)−2−トリフエニルホスホラニリデン酢酸・ジ
フェニルメチルェステル(12:R=PhC&OCO;
R=CHPh2)−上記モノクロル酢酸譲導体(11:
R=PhCH20CO;R=CHPh2:R″=C比:
X′′=CI)89夕(0.015mole)を塩化メ
チレン100Mにとかし〜これにトリフエニルホスフイ
ン8.0夕(0.03hole)を加え、1.期時間加
熱還流する。After cooling on ice for 3 minutes, add an appropriate amount of methylene chloride to the reaction solution, and wash with water and brine. After drying, the solvent was distilled off under reduced pressure to obtain the desired monochloroacetic acid derivative (11:R
=PhC ratio OCO; R'=CHPh2:R''=CH3;
]''-CI) 8.9 minutes are obtained. rw chicken skin 3 skin-1:
3435, 1790, 1748, 1725 1502.
{6'2-(28-lupoxymethoxy-30-penzyloxycarbonylamino-4-oxoazetidine-1
-yl)-2-triphenylphosphoranylidene acetic acid diphenylmethyl ester (12:R=PhC&OCO;
R=CHPh2)-the above monochloroacetic acid derivative (11:
R=PhCH20CO; R=CHPh2:R″=C ratio:
Dissolve 0.015 mole of X''=CI) in 100 M methylene chloride to which 8.0 mole of triphenylphosphine (0.03 mole) is added.1. Heat to reflux for a period of time.
次いで、これにトリフエニルホスフイン2.0夕(7.
5mmole)を追加し、更に1時間加熱還流する。反
応液を5%炭酸水素ナトリウム水に注ぎ、中和して、塩
化メチレンで抽出する。抽出液を水、食塩水で順次洗浄
後、乾燥、溶媒を減圧留去して得られる残澄をシリカゲ
ル300夕のカラムに通して、ベンゼン−酢酸エチル(
4:1〜1:1)で熔出すると、目的のトリフェニルホ
スホラン・メチルエステル、即ち、2−(20−メトキ
シカルボニルメトキシ−38ーベンジルオキシカルボニ
ルアミノ−4‐−オキソアゼチジン−1−イル)一2ー
トリフエニルホスホラニリデン酢酸・ジフェニルメテル
ェステル10.2夕(84.1%収率)が得られる。I
R:〃錦髪3仇‐1:3445・I790・I725・
I630・I5I20NMR:6(CDCl3)肌:3
.58(s、細)、3,6〜5.2(m、4H)、5.
07(s、が)。上記トリフェニルホスホラン1メチル
ェステル16.23夕(20.5mmole)をテトラ
ヒドロフラン240叫にとかし、氷冷下、これに水酸化
ナトリウム水(0.19mmole/似)118叫(2
2.5mmole)を2〜5℃の温度で30分を要して
滴下する。反応液を1粉ン間櫨押した後、2%塩酸44
の【(23mmole)を加えて中和し、酢酸エチルに
て抽出する。抽出液を水「食塩水で洗浄し、乾燥後、溶
媒を減圧留去すると、目的のトリフェニルホスホラン誘
導体(12:R=PhCH20CO:R=CHPh2)
15.8夕が得られる。This was then treated with 2.0 tsp of triphenylphosphine (7.0 tsp).
5 mmole) and further heated under reflux for 1 hour. The reaction solution was poured into 5% aqueous sodium bicarbonate, neutralized, and extracted with methylene chloride. The extract was washed sequentially with water and brine, dried, and the solvent was distilled off under reduced pressure.
4:1 to 1:1), the desired triphenylphosphorane methyl ester, i.e., 2-(20-methoxycarbonylmethoxy-38-benzyloxycarbonylamino-4-oxoazetidin-1-yl) 10.2 times (84.1% yield) of 12-triphenylphosphoranylidene acetic acid/diphenylmether ester are obtained. I
R:〃Nishikami 3 enemies-1:3445・I790・I725・
I630/I5I20NMR: 6 (CDCl3) Skin: 3
.. 58 (s, thin), 3,6-5.2 (m, 4H), 5.
07(s,ga). 16.23 mmole (20.5 mmole) of the above triphenylphosphorane 1 methyl ester was dissolved in 240 mmole of tetrahydrofuran, and 118 mmole (2 mmole) of sodium hydroxide solution (0.19 mmole/similar) was added to this under ice cooling.
2.5 mmole) was added dropwise over 30 minutes at a temperature of 2-5°C. After pressing the reaction solution for 1 hour, add 2% hydrochloric acid
Neutralize by adding (23 mmole) of [(23 mmole), and extract with ethyl acetate. The extract was washed with water and brine, dried, and the solvent was distilled off under reduced pressure to obtain the desired triphenylphosphorane derivative (12:R=PhCH20CO:R=CHPh2).
15.8 evenings are obtained.
IR:レ鴇髪3弧‐1:3440、177i17251
625・1510。【7) 70−ペンジルオキシカル
ボニルアミノ−3−ヒドロキシ−1ーオキサ−1−デチ
ア−3−セフェムー4−カルボン酸・ジフェニルメチル
エステル(ロ:R=PhCH20CO;R′=CHPh
2)−上記トリフェニルホスホラン謙導体(12:R:
PhCH20CO;R′=CHPh2)15.8夕(2
0.3mmole)を無水トルェン300Mにとかし、
これに無水酢酸41.4夕(406mmole)および
NON−ジメチルアセトアミド8.87夕(102肌m
ole)を加えて、100〜1050○(俗温)に16
時間加熱する。IR:Retokami 3 arc-1:3440, 177i17251
625.1510. [7] 70-penzyloxycarbonylamino-3-hydroxy-1-oxa-1-dethia-3-cephemu 4-carboxylic acid diphenylmethyl ester (R=PhCH20CO; R'=CHPh
2)-The above triphenylphosphorane conductor (12:R:
PhCH20CO; R'=CHPh2) 15.8 evening (2
0.3 mmole) in 300M anhydrous toluene,
This was combined with 41.4 mmoles (406 mmoles) of acetic anhydride and 8.87 mmoles (102 mmoles) of NON-dimethylacetamide.
ole) and 16 to 100-1050○ (normal temperature).
Heat for an hour.
袷後、反応液にベンゼンを加え、水、食塩水で順次洗浄
後、乾燥し、溶媒を減圧留去すると、約20夕の残澄が
得られる。これをシリカゲル600夕のカラムに通して
、ベンゼン−酢酸エチル−酢酸(9:1:0.001)
鷹液で溶出すると、3ーアセトキシ−78ーベンジルオ
キシカルボニルアミノ−1−オキサ−1−デチア−3−
セフェム−4−カルボン酸・ジフェニルメチルヱステル
5.08夕(48%収率)(以下3−アセトキシ体と云
う)および副生物としての2−(2−ペンジルオキシカ
ルポニル−3・8ージオキソー5−オキサm2・7ージ
アザビシクロ〔4・2・0〕オクタン−7ーイル)−2
−トリフェニルホスホラニリデン酢酸・ジフェニルメチ
ルヱステル3.25夕(21.5%収率)が得られる。
3−ァセトキシ体の物理恒教職:レ銭暖3肌‐1:34
45、1800、1785 172ふ 1656、15
08。After pouring, benzene was added to the reaction mixture, and the mixture was washed successively with water and brine, dried, and the solvent was distilled off under reduced pressure to obtain a residue of about 20 minutes. This was passed through a silica gel 600 column and a benzene-ethyl acetate-acetic acid (9:1:0.001)
Elution with falcon solution yields 3-acetoxy-78-benzyloxycarbonylamino-1-oxa-1-dethia-3-
Cephem-4-carboxylic acid/diphenylmethylester 5.08 g (48% yield) (hereinafter referred to as 3-acetoxy form) and 2-(2-penzyloxycarponyl-3,8-dioxo 5) as a by-product -oxa m2.7-diazabicyclo[4.2.0]octane-7-yl)-2
-Triphenylphosphoranylidene acetic acid/diphenylmethylester 3.25 hours (21.5% yield) are obtained.
3-Physics of acetoxy body teaching position: Le Qiandan 3 skin-1:34
45, 1800, 1785 172fu 1656, 15
08.
NMR:6(CDCl3)柳:2.00(s、知日)、
4,32(s、が)、5.05(d、J=4HZ、IH
)、5.13(s、が)、5.38(q、J=4および
10HZ、IH)、5.68(d、J=10HZ、IH
)、6.95(s、IH)。副生物の物理恒数IR:レ
錦鞍3の‐1:179o、177& 1740、162
80NMR:6(CDCl3)胸:3〜4(m、2H)
、4〜5(m、汎)、5.27(s、が)。NMR: 6 (CDCl3) Yanagi: 2.00 (s, Chihito),
4,32 (s, ga), 5.05 (d, J=4HZ, IH
), 5.13 (s, ga), 5.38 (q, J = 4 and 10HZ, IH), 5.68 (d, J = 10HZ, IH
), 6.95 (s, IH). Physical constants of by-products IR: Les Kinkura 3-1: 179o, 177 & 1740, 162
80NMR: 6 (CDCl3) Chest: 3-4 (m, 2H)
, 4-5 (m, general), 5.27 (s, ga).
上記3ーアセトキシ体3.2夕(5.9mmole)を
ピリジン60の‘および水12叫の混液に袷時とかし、
室温にて1.7虫時間嬢幹する。3.2 mmoles (5.9 mmole) of the above 3-acetoxy compound was dissolved in a mixture of 60 parts of pyridine and 12 parts of water,
Stir for 1.7 hours at room temperature.
反応液を氷中に注ぎ、酢酸エチルで抽出する。酢酸エチ
ル抽出液を水、10%リン酸、水、食塩水で順次洗浄し
、乾燥後、溶媒を減圧蟹去すると、目的の3ーヒドロキ
シ体(D:R:PhC比OCO;R′=CHPh2)3
.05夕が白色泡状物質として得られる。IR:レ誌髭
〆3伽1:3440・1795・1725・1675、
1625、15100NMR:6(CDCl3)肌:4
.37(s、が)、5.05(d、J=4HZ、IH)
、5.18(s、2H)、5.45(q、J=loHZ
、IH)、5.72(d、J=10HZ、IH)、7.
00(s、IH)、10.83(s、IH)。本品は実
施例1における原料化合物として使用し得る。Pour the reaction mixture into ice and extract with ethyl acetate. The ethyl acetate extract was washed successively with water, 10% phosphoric acid, water, and brine, dried, and the solvent was removed under reduced pressure to obtain the desired 3-hydroxy form (D:R:PhC ratio OCO; R'=CHPh2). 3
.. 05 is obtained as a white foam. IR:Reshi Higeshi〆3佽1: 3440, 1795, 1725, 1675,
1625, 15100NMR: 6 (CDCl3) Skin: 4
.. 37 (s, ga), 5.05 (d, J=4HZ, IH)
, 5.18 (s, 2H), 5.45 (q, J=loHZ
, IH), 5.72 (d, J=10HZ, IH), 7.
00 (s, IH), 10.83 (s, IH). This product can be used as a raw material compound in Example 1.
Claims (1)
−デチアセフアロスポラン酸化合物(式中、 R^1は水素原子、ハロゲン原子、低級アルコキシ基
、低級アルキルスルホニルオキシ基、アリールチオ基ま
たはメチルテトラゾリルチオ基; R^2はCOOHま
たは(ニトロまたはフエニル)ベンジルオキシカルボニ
ル基; R^3は水素原子またはメトキシ基; をそれぞれ表わす)。[Claims] 1 7-amino-3'-nor-1-oxa-1 represented by the general formula ▲ Numerical formula, chemical formula, table, etc. ▼
- dethiacephalosporanic acid compound (wherein R^1 is a hydrogen atom, a halogen atom, a lower alkoxy group, a lower alkylsulfonyloxy group, an arylthio group or a methyltetrazolylthio group; R^2 is COOH or (nitro or phenyl)benzyloxycarbonyl group; R^3 represents a hydrogen atom or a methoxy group; respectively).
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP51093809A JPS609514B2 (en) | 1976-08-05 | 1976-08-05 | 7-amino-3'-norcephalosporanic acids |
CA283,808A CA1090336A (en) | 1976-08-05 | 1977-07-29 | Cephalosporin analogues |
GB32111/77A GB1552099A (en) | 1976-08-05 | 1977-08-01 | Cephalosporin analogues |
IL52668A IL52668A (en) | 1976-08-05 | 1977-08-04 | 7 -amino-1-oxa-1-dethiacephalosporins and their preparation |
FR7724055A FR2360594A1 (en) | 1976-08-05 | 1977-08-04 | NEW SIMILAR CEPHALOSPORIN COMPOUNDS |
BE179912A BE857482A (en) | 1976-08-05 | 1977-08-04 | NEW ANALOGUES OF CEPHALOSPORINS |
IE1630/77A IE45459B1 (en) | 1976-08-05 | 1977-08-04 | Cephalosporin analogues |
NL7708722A NL7708722A (en) | 1976-08-05 | 1977-08-05 | CEPHALOSPORINE ANALOGS. |
DE19772735408 DE2735408A1 (en) | 1976-08-05 | 1977-08-05 | 7 BETA-AMINO-1-OXADETHIACEPHALOSPORINE |
CH965277A CH637135A5 (en) | 1976-08-05 | 1978-01-01 | Cephalosporin derivatives and a process for their preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP51093809A JPS609514B2 (en) | 1976-08-05 | 1976-08-05 | 7-amino-3'-norcephalosporanic acids |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5318597A JPS5318597A (en) | 1978-02-20 |
JPS609514B2 true JPS609514B2 (en) | 1985-03-11 |
Family
ID=14092721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51093809A Expired JPS609514B2 (en) | 1976-08-05 | 1976-08-05 | 7-amino-3'-norcephalosporanic acids |
Country Status (10)
Country | Link |
---|---|
JP (1) | JPS609514B2 (en) |
BE (1) | BE857482A (en) |
CA (1) | CA1090336A (en) |
CH (1) | CH637135A5 (en) |
DE (1) | DE2735408A1 (en) |
FR (1) | FR2360594A1 (en) |
GB (1) | GB1552099A (en) |
IE (1) | IE45459B1 (en) |
IL (1) | IL52668A (en) |
NL (1) | NL7708722A (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4197402A (en) * | 1976-08-09 | 1980-04-08 | Shionogi & Co., Ltd. | Cephalosporin analogues |
GB1557552A (en) * | 1977-02-15 | 1979-12-12 | Shionogi & Co | 1 oxadethiacepham compounds |
IT1102408B (en) * | 1977-12-23 | 1985-10-07 | Fujisawa Pharmaceutical Co | ANALOGUE COMPOUNDS OF CEPHALOSPHORINE AND PROCEDURES FOR THEIR PREPARATION |
CA1262128A (en) * | 1981-08-27 | 1989-10-03 | Christian N. Hubschwerlen | .beta.-lactams |
JPS5910591A (en) * | 1982-07-09 | 1984-01-20 | Meiji Seika Kaisha Ltd | 1-oxadethiacephalosporin compound and antibacterial agent containing the same |
HRP970146A2 (en) * | 1997-03-13 | 1998-10-31 | Mice Kovacevic | Epoxi-azetidines, preparation and use |
-
1976
- 1976-08-05 JP JP51093809A patent/JPS609514B2/en not_active Expired
-
1977
- 1977-07-29 CA CA283,808A patent/CA1090336A/en not_active Expired
- 1977-08-01 GB GB32111/77A patent/GB1552099A/en not_active Expired
- 1977-08-04 IE IE1630/77A patent/IE45459B1/en unknown
- 1977-08-04 FR FR7724055A patent/FR2360594A1/en active Granted
- 1977-08-04 BE BE179912A patent/BE857482A/en not_active IP Right Cessation
- 1977-08-04 IL IL52668A patent/IL52668A/en unknown
- 1977-08-05 DE DE19772735408 patent/DE2735408A1/en not_active Ceased
- 1977-08-05 NL NL7708722A patent/NL7708722A/en not_active Application Discontinuation
-
1978
- 1978-01-01 CH CH965277A patent/CH637135A5/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IL52668A0 (en) | 1977-10-31 |
FR2360594A1 (en) | 1978-03-03 |
IE45459B1 (en) | 1982-08-25 |
CA1090336A (en) | 1980-11-25 |
IE45459L (en) | 1978-02-05 |
IL52668A (en) | 1981-03-31 |
DE2735408A1 (en) | 1978-02-09 |
BE857482A (en) | 1978-02-06 |
JPS5318597A (en) | 1978-02-20 |
FR2360594B1 (en) | 1980-02-08 |
NL7708722A (en) | 1978-02-07 |
GB1552099A (en) | 1979-09-05 |
CH637135A5 (en) | 1983-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI63237B (en) | FOERFARANDE FOER FRAMSTAELLNING AV 3-METHYL- OCH 3-HYDROXI-7-AMINO-1-OXACEF-3-EM-4-OINSYRADERIVAT VILKA AER ANVAENDBARA SOMMELLANPRODUKTER VID FRAMSTAELLNING AV ANTIBIOTIKA | |
EP1767538B1 (en) | Process for producing 1-oxacephalosporin-7alpha-methoxy-3-chloromethyl derivative | |
SE444811B (en) | AZETIDINYL SUBSTANCE FOR THE PREPARATION OF 3-HYDROXY-CEFEM SUBSTANCES AND PROCEDURE FOR ITS PREPARATION | |
GB2128986A (en) | Derivatives of 6 b-hydroxalkylpenicillanic acids as b-lactamase inhibitors | |
JPH0149271B2 (en) | ||
JPS609514B2 (en) | 7-amino-3'-norcephalosporanic acids | |
FR2580652A1 (en) | 7-AMINO-3-PROPENYLCEPHALOSPORANIC ACID AND ITS ESTERS | |
US4603014A (en) | Thiazolinoazetidinone derivatives and process for the preparation of the same | |
IL33057A (en) | 2-acyloxycephalosporin compounds having antibiotic activity,intermediates useful in their preparation and process for preparing said compounds and intermediates | |
US4031084A (en) | Process for cephalosporin antibiotic intermediates | |
JPH03178980A (en) | Production of 3-substituted thio-3-cephem compound | |
US4281117A (en) | Process for 3-chloro cephalosporin nucleus | |
IE50650B1 (en) | Method for producing penicillanic acid derivatives | |
JPH07215952A (en) | Catechol derivative | |
US4048155A (en) | Process for preparing 7 α-alkoxycephalosporin derivatives | |
US3985746A (en) | 7-(α-Cyanomethylthio)acetamido-3-cephem carboxylates | |
JPH054990A (en) | Amination of 3-halogenated cephalosporin compound | |
FI93359C (en) | Process for the preparation of 7- (protected amino or acylamino) -3-methyl-1-carba- (1-detia) - (2 or 3) -cephem-4-carboxylate compounds | |
PL114624B1 (en) | Process for preparing novel cephem derivatives | |
CS196420B2 (en) | Method of producing 1-dethia-1-oxacephamderivatives | |
EP0160564B1 (en) | Process for preparing cephalosporin compounds | |
JPS61246187A (en) | 1-oxadethiacepham compound | |
JPH0613528B2 (en) | Method for methoxylation of cefm compounds | |
KR810000714B1 (en) | Process for preparing 1-oxadethiacepham compounds | |
KR810000715B1 (en) | Process for preparing 1-oxadethiacepham compounds |